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bacteriophage T4 enzymes involved in deoxyribonucleotidebiosynthesis are
associated as a complex within the infected Escherichiacoll. This dissertation
describes the continued examination of the protein-proteininteractions
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CHAPTER 1
Introduction
Background
Bacteriophage T4 has been an essentialelement in the birth and
development of molecular biology. Theknowledge gained during this infancy
and adolesence has broughta wealth of information about the biochemistry
involved in bacteriophage T4 replicationwithin the host, Escherichia coli.
More importantly research dealingwith bacteriophage T4 has giveninsights
into fundamental processes of allliving systems. A number of current
biochemical paradigmswere first investigated and described by using
bacteriophages. Examples include thediscoveries of genetic information
being encoded in DNA, the geneticcode being read from a fixed startingpoint
in triplets, and the identification ofmessenger RNA. These basic processes
and many others were revealed throughthe model system bacteriophageT4.
The enzymology of deoxyribonucleotidebiosynthesis represents one of the
classical and best studiedareas of T4 biochemistry. In general allorganisms
that contain DNA are required toprovide more than justan adequate supply of
the four deoxynucleotides. Toprevent misincorporation during DNA
replication the supply of eachdeoxyribonucleoside triphosphate mustalso be
balanced relative to the levels of theother three deoxyribonucleoside
triphosphates. The bacteriophage T4as a model system provides a powerful
tool to further investigate the propertiesand interactions in this delicately
balanced system.
This dissertation describesseveral approaches to understandingthe
interactions of the enzymes involvedin a deoxynucleotide biosynthesis
complex. The first chapter isa review of bacteriophage T4 and theenzymes2
that are involved in deoxynucleotide biosynthesis.This will be followed by two
manuscripts. The first, chapter 2, describes theinitial identification of an
interaction between bacteriophage T4 thymidylatesynthase and dCMP
hydroxymethylase using an anti-idiotypic antibodyas an immunological probe.
Chapter 3 describes the purification of thephage thymidylate synthase and
dCMP hydroxymethylaseenzymes. Chapter 4 describes the investigation to
understand the interactions betweena bacteriophage T4 translational
regulator, RegA, and the enzymes involvedin dNTP biosynthesis. The final
section will discuss the implication of thework described in the manuscripts
and their general importance.
Introduction to Bacteriophage T4:
Bacteriophage T4 History and its ReplicationMachinery
The original foundation for the studyof bacteriophages started with
Frederick Twort's discovery in 1915 ofa new phenomenon, the lysis of bacteria
(Twort, 1915). By 1917 Felix d'Herellepostulated the concept that
bacteriophagy was caused byan organism parasitizing bacteria (d'Herelle,
1917). Continued research byd'Herelle led to his quantitation ofhis findings
and the development of the plaquemethod, which becamea powerful tool
both in bacteriophage and animalvirus research (d'Herelle, 1922).
The early research that followedthese initial findings was spurredon by the
belief that bacteriophages wouldprove to be powerful therapeutic agents in
the fight against bacterial infection.As early as 1926, articles describingthe
attempt to control a variety of epidemicswith bacteriophageswere being
published in journals (Schumm et al.,1926). While bacteriophagesdid fail in
their role as therapeutic agents, theresearch on the phages' uniqueproperties3
and general biology continued.
Bacteriophage T4 itself was not isolated until1945 by Milislav Demerec,
and by this time a bewildering variety ofbacteriophages had been identified
with a wide range of characteristics.Max Delbruck selected a small numberof
phages from the Demerec collection that hehoped would be a foundation for
future research (Waterson and Wilkinson,1978). Delbrilick believed that the
seven isolates were distinct types of bacteriophagesand designated them T1
through T7, the "T" standing for "type"(Calendar, 1988). Later itwas
recognized that Delbruck had not selectedseven distinct phages but that the
T-even phages, T2, T4, and T6,are a related clan, while T3 and T7 forma
second distinct group.
In the past decade the study ofbacteriophage T4 has revealeda number of
surprises about this classic laboratoryorganism. Bacteriophage T4,
supposedly an entrenched representativeof the prokaryotic kingdom, has
demonstrated several biochemical characteristicsthat had once been thought
to be unique to the eukaryotic world.
One of the recent surprises is thedemonstration that three bacteriophage
T4 genes: td, thymidylate synthase;nrdB, the small subunit of ribonucleotide
reductase; and sunY, a putative anaerobicribonucleotide reductase,were
demonstrated to contain group I intronsthat are also found in certain
eukaryotic RNAs (Shub and Belfort, 1988).The biological role of the intronsis
currently unknown. Also, the significanceof the fact that the bacteriophageT4
introns all likely reside withindeoxynucleotide biosynthesisenzyme genes is
an unanswered question.
Another surprise recognized withinthe last decade involved the T4DNA
replication enzymes. Amino acidsequence analysis (Spicer and Konigsberg,4
1988) demonstrated that the T4 DNApolymerase contains the six conserved
functional domains that characterize theeukaryotic DNA replication
polymerases (Wong and Wang, 1988). A strikingobservation is that while the
T4 DNA polymerase shows homologousdomains with the eukaryotic
polymerases the E. coli polymerases donot contain these functional domains
and have low sequence similarity.
Besides the polymerases' similaritiesthe human replication factor C and
proliferating-cell nuclear antigen, PCNA,have been shown to be "completely
analogous" in function to the T4 DNApolymerase accessory proteins
(Tsurimoto and Stillman, 1990). Thehuman proliferating-cell nuclearantigen
has 31-50% homology withgene 45, a DNA polymeraseaccessory protein in
bacteriophage T4 that stimulatesa DNA-dependent ATPase activity. PCNA
can also stimulate the human replicationfactor C ATPase activity, andcan be
functionally replaced in vitro with theT4 gene product 45. As in thecase with
the DNA polymerases the (3 subunitof E. coli, which has been proposedto
have a function similar to PCNA(Tan and Downey, 1986), showsalmost no
amino acid homology.
While bacteriophage T4represents one of the best understoodorganisms
in its biochemistry,very little is known about its evolution.Are modern day T-
even bacteriophages ancient organisms thatarose with the first bacteria,or is
the recruitment of hostgenes to generate new virusesa frequent ongoing
process, with the T-even bacteriophagesbeing the latest development?
Tsurimoto and Stillman postulatethat during the developmentof
eukaryotes an ancestral bacteriophageT4 type polymerasegene as well its
accessory genes duplicated and divergedto function in the eukaryotic cells.
This model thatproposes a vertical acquisition of geneticinformation to explain
the similarity between T4 andeukaryotic genes is butone of several possible5
scenarios to explain the homology.
While bacteriophage T4 is well known for itspowerful ability for DNA
recombination, little is currently known about theinteractions of phages in the
wild with other organisms.It has been proposed that the mammaliangut is the
major natural environment of T-even phages(Kutter, 1992), and a horizontal
transmission of genetic information between T4and eukaryotes after the
divergence of prokaryotes and eukaryotes couldbe an alternate explanation
for the homology.
I would propose that withoutany conclusive evidence on the antiquity of T-
even bacteriophages, even the direction of horizontaltransmission of genetic
information cannot be made. An unlikelybut still possible explanation of the
T4 and eukaryotic homology is that theT-even bacteriophagesare
evolutionary recent chimeras of prokaryoticand eukaryotic information.
Composition of Bacteriophage T4
Bacteriophage T4, along with its clanmembers, T2 and T6, is the most
structurally complex of the T phages.Bacteriophage T4 is among the largest
viruses ever isolated, with a DNAcontent of around 171 kb containing 3 %
terminal redundancy. The T4genome contains approximately 200open
reading frames that are often organizedinto groups of relatedgene products or
"constellations" (Figure 1-1). The completesequence for bacteriophage T4 has
yet to be determined. At the current timemore than 90% of the genome has
been sequenced and the remainingunread areas often represent the
connections between gene constellations.
Bacteriophage T4 DNA is quite low inthe percentage of GC basepairs,with
only 36% of the basepairs being GC. Aswill be discussed later inmore detail
the T4 DNA contains not C, buthydroxymethylated deoxycytidine that is
glycosylated.co
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The large size of the bacteriophage T4genome relative to its host E. coil is
quite remarkable. By comparing either the complexity ofgene regulation or the
relative amount of DNA, bacteriophage T4 hasa size and complexity that is
one of the closest to its host's of any virus.
Bacteriophage T4 Infection Cycle
After the initial injection of T4 DNA into the E. coilcell, the host RNA
polymerase transcribes a set of phagegenes encoding nucleases, which
cleave the host DNA for later salvage of deoxynucleosidetriphosphates,
dNTPs (Kutter and Wiberg, 1968). The host DNAis thought to receive a large
number of single strand breaks, which becomegaps and finally develop into
double strand cleavages (Warner and Snustad,1983). While the viral
nucleases are being made the synthesis of all hostproteins and mRNA ceases
(Cohen, 1968). The shutdown of the hostsynthesis is dependent upon an
initial ADP-ribosylation of the host's RNApolymerase a subunits (Goff and
Weber, 1970) and a number of T4gene products (Goff and Selzer, 1980).
Additional phage gene productsare made within the first 12 minutes after
infection and are classified as either immediateearly or delayed early genes
(Brody et al., 1983). One group of immediateearly genes is transcribed only
for the first 4 minutes, while the restare made throughout the 12 minutes of
early gene expression (Figure 1-2). Thedelayed early genes commence
transcription 2 minutes after infection andare dependent upon T4 proteins for
their synthesis. These genes allow denovo synthesis of deoxynucleotides
and T4 DNA replication.8
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Figure 1-2. Bacteriophage T4 Life Cyclefrom Mathews, 19779
The replication of T4 DNA usually begins5 minutes after infection at 37°C
as does additional ADP-ribosylation of the host RNApolymerase (Rabussay,
1982). T4 late transcription is dependentupon concurrent DNA replication
(Lembach et al., 1969). The signal forexpression of the late genes in
bacteriophage T4 is also dependentupon the presence of hydroxymethylated
dCMP sequences and the interaction ofat least four virally encoded subunits
that interact with the host RNA polymerase(Wu and Geiduschek, 1975). The
late gene products code for structuraland packaging proteins that createthe
well known icosahedral shaped phagehead and contractile tail.
T4 DNA Replication, Recognitionof Self Versus Host
The rate of T4 DNA synthesis is10- fold higher than that in theuninfected
E. coli (Mathews, 1972).It takes the host, E. coli, 40 minutesto replicate its
4000-kbp genome using 2 replicationforks at a rate of 850
nucleotides/second. However, E. coli isable to divide every 20 minutes under
optimal conditions by startinga second round of DNA replication whilethe
parental genomes are only only halfreplicated. Under these conditions6
replication forks can be active atany one time in a given E. coli cell. An
average T4 infection contains 60 replication forksper host cell, and up to 200
phage particles can be synthesizedfrom one infected E. coil within25
minutes (Mathews, 1993).
The large size of T4 relativeto its host means that only 10% ofthe required
deoxynucleotides can be salvaged fromthe host DNA, while the restmust
come from de novo synthesis. The E. coli chromosome,in other words, is
only 20 times larger than eachindividual phage genome. The T4replicative
chain growth of 700 to 800 nucleotidesper second demonstrates that the T410
DNA polymerase is operating under whatappear to be ideal conditions and is
not limited by lack of dNTPs (Mathews, 1988).This high rate of synthesis does
not fit with the observed concentrations ofdeoxyribonucleoside triphosphates
seen in the infected E. coli. The average concentrationover the entire cell is
only about 100 ptM, while the replicationforks are not saturated in vitro untila
concentration of 250 gM for each of the fourdNTPs (Mathews and Sinha,
1982).It has been proposed and will bediscussed in more detail latter in this
chapter that the actual localized concentrationat the replication forks is higher
than the overall cell concentration.
As stated above, the synthesis of theviral nucleases which break downthe
E. coli chromosome can augmentthe supply of deoxynucleotides forT4 DNA
synthesis. However, the T4 DNAreplication machinery is then requiredto
operate in a very inhospitable environmentfor the synthesis of itsown DNA.
To be able to have intact phage DNAunder these conditions the T4nucleases
have to be able to distinguish betweeninformation that is coding for selfversus
information that was part of the host'schromosome. This selectivity is made
possible by the unique features of T4deoxyribonucleotide biosynthesis.
Specifically, the synthesis of5-hydroxymethyldeoxycytidylate (hmdCMP)by
the enzyme dCMP hydroxymethylaseallows salvage and phage DNA
replication to coexist. T4 DNA containinghydroxymethylated cytosine is
protected from its own cleavagesystem.
An additional modification of thephage DNA, the glucosylation ofthe
hydroxymethyl groups of the modifiedcytosine, occurs after dNTPs havebeen
incorporated into DNA. The glucosylationconfers resistance to host restriction
systems (Hewlett and Mathews, 1975).In T4 DNA 70% of the hydroxymethyl
cytosine residues are a-glucosylated,and 30% are modified in the 1311
configuration (Mathews and Allen, 1983). The two differentglycosylation
reactions are catalyzed by two phage-encodedglucosyltransferases, encoded
by genes a-gt and p-gt. Phages are viableas long as at least one functional
gene is present. Computer modeling of glucosylated bacteriophageT4 DNA
suggests that the glucose residuescan occupy the major groove and thereby
block the recognition sites of the E. coli restrictionenzyme systems (Figure I-
3).
A critical step for T4 DNA replication is limitingthe insertion of unmodified
cytosine into DNA. Even a very low insertionfrequency of unmodified cytosine
could make a 166-kbp T4 genome, which issurrounded in a milieu of viral
nucleases, damaged and nonviable for furtherinfections. This makes it
somewhat surprising that the T4 DNA polymerasedoes not distinguish
between dCTP and hmdCTP. It can be assumedthat under these in vivo
conditions the T4 DNA polymerase does notcome in contact with unmodified
dCTP. In fact the unmodified dCTP pool isbelow measurable levels by five
minutes post infection (Mathews, 1972).
What structures or enzymes allow thisto take place inside the infected E.
coli? An erroneous initial assumption wouldbe that the dCMP
hydroxymethylase is a very efficientenzyme where it rapidly modifies the
dCMP even under conditions where the dCMPis at very low concentrations.
This turns out to not be thecase in vitro. The purified dCMP
hydroxymethylase has a high Km of 600 p.M (Pizerand Cohen, 1962) and a
slow turnover of 276 moles hmdCMP/ moledCMP hydroxymethylase/minute
(North and Mathews, 1977).12
Figure 1-3. The Structure of Bacteriophage T4 Glucosylated DNA. A model of
DNA containing a space filled a-glucosylated hydroxymethyl cytosine residue.
The glucose molecule was allowed to rotate to the lowest minimumenergy for
the model. (model was created by Dr. Shing Ho)13
How is unmodified dCTP prevented from beingincorporated into T4 DNA
when the final enzyme in the biosyntheticpathway, DNA polymerase, does not
distinguish between hmdCTP and dCTP, and themodifying enzyme, dCMP
hydroxymethylase, functions slowly and requireshigh substrate
concentrations? The answer in part lies withrecognizing the mistake of
examining individual enzymes separate fromthe context of the overall
pathway. Assumptions of what specific catalyticproperties an individual
enzyme should have to make an overall pathway themost efficient cannot be
made without understanding the propertiesand interactions of all theenzymes
involved in the pathway.
For bacteriophage T4 the overalldeoxypyrimidine pathwayappears to
have been modified by evolution toprevent the incorporation of dCTP by the
T4 polymerase. One importantmodification of the T even bacteriophage
deoxynucleotide biosynthesis pathway isthe expansion of the viral dUTPase
substrate specificity to include dCTP anddCDP. The bacteriophage
dCTPase/dUTPase, gene product 56, hasa turnover of approximately 8,000
moles product/mole enzyme/minutefor dCTP and 1,600 for dCDP (Zimmerman
and Kornberg, 1961) with Km valuesof 4.311M and 2.4 gM, respectively.
These values for dCTPare close to the dUTP turnover and Km values forthe
enzyme.
While it appears that natural selectionhas made the T4 dUTPase less
specific in its choice of substrate, anotherenzyme, deoxynucleoside
monophosphate kinase, has apparentlyundergone a much more complicated
substrate specificity evolution.
The T4 deoxyribonucleotide biosynthesispathway contains a14
deoxynucleoside monophosphate kinase,gene product 1, which can transfer a
phosphate from ATP to either dGMP, dTMP,or hmdCMP (Brush and Bessman,
1990). The dNMP kinase isa small homodimer (Sakiyama and Buchanan,
1973) with a subunit molecular weightof 27,300. All three deoxynucleoside
monophosphates have been shown to becompetitive inhibitors of each other
(Bello and Bessman, 1963). The competitionfor catalysis is a strong indication
that there is one active site that is sharedby the three deoxynucleoside
monophosphates. However, the possibilitythat there are three active sites
which overlap or thata substrate-induced conformational changetakes place
cannot be conclusively ruled out.
What is surprising for anenzyme that recognizes three structurally
dissimilar nucleotides is the exclusionof unmodified dCMPas a suitable
substrate. The T4 dNMP kinase hasnot only evolved the ability to
accommodate hmdCMP in the active sitebut can recognize the absence ofthe
hydroxymethyl group and excludedeoxycytidine that is unmodified.
The mechanism that requires dCMPto contain a hydroxymethylgroup at
the 5 position to be a substrate fordNMP kinase is still not understoodand
probably will stay an enigma untilthe structure of dNMP kinase withhmdCMP
bound in its active site is solved.
T4 Deoxyribonucleotide Biosynthesis:
Enzymes Involved in T4 DeoxyribonucleotideBiosynthesis
In general ribonucleotidesserve a multitude of functions withinorganisms.
They serve as theprecursor for RNA, as carriers ofenergy metabolism, as
components of coenzymes, andas metabolic regulators. On the otherhand,
deoxyribonucleotides are used almostexclusively for the synthesis ofDNA,
and their concentrations found inliving systems representa small fraction the15
size of the ribonucleotide pools. While the size of thedeoxynucleotide pools
may be in the minority their proper regulation is vital for all livingorganisms
that contain DNA (Reichard,1988)
The enzymes involved in T4 deoxyribonucleotidebiosynthesis have been
recognized for the past 30 years, with the exceptionof the T4 gene sunY
product, which is currently being investigatedby Britt-Marie Sjoberg as a
possible anaerobic ribonucleotide reductase.Table 1-1 lists the enzymes
involved in T4 deoxynucleotide biosynthesis withtheir reported apparent Km
and turnover values. Several of the reportedvalues were determined for
enzymes encoded in related T-even phages other thanbacteriophage T4.
Various kinetic values have been publishedfor the T4 thymidylate synthase in
the past. The Km and turnover values for T4thymidylate synthase shown in
Table 1-1 were values derived from experimentsdescribed in Chapter 4 using
the cloned enzyme. Figure 1-4 diagramsthe deoxynucleotide biosynthesis
pathway for bacteriophage T4.
Ribonucleotide Reductase
The committed step in the specializationand removal of deoxy-
ribonucleotides as a substrate for otherpathways involves the replacement of
the 2' hydroxyl moiety of the ribosesugar by a hydride ion. This first unique
step in the flow of precursors to DNA is catalyzedby the enzyme ribonucleotide
reductase (Reichard and Ehrenberg, 1983).In most organisms, including
bacteriophage T4, ribonucleotide reductasecarries out the reduction at the
ribonucleoside diphosphate level. However,in a minority of organisms,
Euglena, cyanobacteria, and certainbacteria, the reduction is carried outat
the ribonucleoside triphosphate level(Mathews and van Holde, 1990). The
E.coli anaerobic ribonucleotide reductasealso carries out the reduction at the
triphosphate level.All ribonucleotide reductases thathave been studied likely
use a free radical mechanism to extract the 2' hydroxylmoiety (Stubbe, 1990).16
Table I-1. Survey of T4 Enzymes Involvedin Deoxyribonucleotide Biosynthesis
Enzyme Gene SubstrateProduct Km1 Turnover2 Allosteric Regulation
stimulation inhibition
Ribonucleotide reductase3 nrdA/nrdB CDP dCDP 43µM 245dATP /ATP/hm -dCTP
UDP dUDP 100 LIM dATP/ATP/hm-dCTP
GDP-dGDP 45 p.A1 dTTP dATP
ADP -
glutaredoxin-(SH)2
dADP 48 p.M
glutaredoxin -(S)2
dGTP
dCTPase/dUTPase4 56 dCTP-dCMP 4.2W8,357
dCDP-dCMP 2.2 ufv11,671
dUTP-dUMP 11,143
dUDP -dUMP 2,229
dCMP deaminase5 cd dCMP -dUMP 100 p.M31,605 hm<ICTP dTTP
Dihydrofolate reductase6frd FH2-FH4 2.3 plut4,350
NADPH -NADP+18µM
Thymidylate synthase7td dUMP -dTMP 7µM 607
CF12F1-(4-CH2FH243 gm 912
dCMP hydroxymethylase8 42 dCMP hm-dCMP 6001.1M 276
CH2FH4-CH2FH4 100 gm
dNMP kinase9 1 tim-dCMP-hm-dCDP 56 p.M 250
dTMP -dTDP 300 p.M 500
dGMP -dGDP 85 p.M 500
ATP-ADP 800 uM
1) Apparent Km
2) moles product/moles enzyme/minute
3) Km, Berglund, (1972A); turnoverand regulation, Berglund (1972B)
4) Zimmerman and Kornberg, (1960)
5) Km, turnover, Scocca, et al., (1969);regulation data from T2 dCMP deaminase
6) Erickson and Mathews, (1972)
7) Determination from experiment doneby this author discussed in Chapter 3.
8) Km For T6 enzyme, Pizer and Cohen,(1962): turnover T4 enzyme, North and
9) T2 enzyme, Bello and Bessman,(1963)
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Figure 1-4. Deoxyribonucleotide BiosynthesisPathway from Mathews and
Allen, 1983. Bold arrows correspondto enzymes encoded by the
bacteriophage T4.18
The bacteriophage T4 and the E. coliribonucleotide reductases are a2[32
tetramers. This structure is analogous to theribonucleotide reductase found in
mammalian cells. The bacteriophage T4and E. coli ribonucleotide reductase
also resemble the higher eukaryotic formin containing two unusual
characteristics present in the small subunitsof all a2132 reductases, a tyrosine
radical and an oxygen atom bridgingtwo ferrous ions. The function of the
binuclear iron center is believed to involvestabilization of the tyrosine radical.
The source of the electrons for thereduction of the ribose originates from
NADPH, with the reducingpower usually transferred by redox-active proteins
to thiol groups on the large subunits (Figure1-5).
The bacteriophage T4 ribonucleotidereductase regulation has certain
similarities with the host enzyme'sregulation. Both enzymesare allosterically
regulated by deoxynucleoside triphosphates,which determine the substrate
specificity by changing both the Km andthe Vmax (Berglund, 1972). Lowlevels
of ATP and dATP stimulate thereduction of pyrimidine ribonucleotides.
Increased levels of dTTP stimulate thereduction of dGTP, while dGTP itself
stimulates the synthesis of dATP.
A major difference between thebacteriophage and host reductasesis that
the purified T4 reductase hasno feedback regulation, in terms of pyrimidine
reduction. The E. coilenzyme in the presence of high levels of dATP,> 10-5
M, is inhibited in reduction of allfour substrates. The bacteriophageT4
reductase is not feedback regulatedby high levels of dATP, and infact dATP
stimulates pyrimidine reduction(Berglund, 1972). Recent workin our lab
suggests that the T4 ribonucleotidereductase is feedback sensitive invivo
and that protein-protein interactionsmay play a role in the regulation (Ji etal.,
1991).R1
(a. 2)
R2
(132)
A4
Specificity site
ATP, dATP
dGTP,dTTP
ADP, CDP
UDP, GDP
Catalytic Site
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Figure 1-5. Bacteriophage T4 Ribonucleotide Reductase. The largesubunits,
R1 contain both a specifity site and a catalytic site. The small subunitcontains
at least one tyrosine radical which is required for catalysis. The tyrosine
radical is buried within the small subunit and noton the surface.20
dCMP Hydroxymethylase and Thymidylate Synthase
The second unique feature of deoxynucleotides isthe modification of the
uracil base to thymine. In bacteriophage T4an additional modification takes
place where cytosine is also hydroxymethylated.These modifications are
carried out by the related enzymes thymidylatesynthase and the enzyme
unique to T-even phages, dCMP hydroxymethylaseThe majority of my work
described in this thesis involves the investigationand understanding of a
protein-protein interaction of the T4 thymidylate synthasewith the dCMP
hydroxymethylase.
Both enzymes catalyse similar reactions,with thymidylate synthase
catalyzing the reductive methylation of deoxyuridinemonophosphate (dUMP)
by 5,10-methylenetetrahydrofolate (CH2-H4folate)to form thymidine
monophosphate (dTMP) and dihydrofolate (H2folate).The dCMP
hydroxymethylase, gene product 42, catalysesthe non-reductive
hydroxymethylation of deoxycytidylate (dCMP)by CH2-H4folate to
hydroxymethyldeoxyctidylate (hmdCMP) and H4folate(Figure 1-6). The dCMP
hydroxymethylase was in fact the first DNAprecursor biosynthesis enzyme
identified to be induced by the bacteriophageT4 (Flaks and Cohen, 1957).
The mechanism for catalysis for bothdCMP hydroxymethylase and
thymidylate synthase has been proposedto involve the formation of a covalent
bond between a nucleophilic cysteinethiol side chain and the C-6 of the dNMP
(Figure 1-7). A second covalent bondis postulated to form between the C-5
position of the dNMP and the5,10-methylenetetrahydrofolate (Moore et al.,
1986).dCMP Hydroxymethylase
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Figure 1-6. Thymidylate Synthase and dCMPHydroxymethylase Reactions22
Figure 1-7. Proposed Mechanism for Thymidylate Synthase
Formation of a covalent bond between a catalytic thiol and dUMP
generates a resonance-stabilized anion. The C-5 atom on dUMP becomes a
nucleophile and carries out a condensation reaction with the activated form of
the cofactor, 5-CH2=H4. A basic group on the enzyme had been postulated to
abstract a proton from C-5. However, no such basic group has been identified
in X-ray crystallography. Elimination and hydride transfer from C-6 of the
tetrahydrofolate cofactor produces dTMP and the oxidized cofactor,
dihydrofolate (Finer-Moore et al, 1990).dTMP
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Because thymidylate synthaserepresents the only de novo pathway for
the synthesis of dTMP theenzyme mechanism has been studied ingreat detail
in hopes of developing potent anticancerdrugs. Thymidylate synthase isan
obligate dimer, with components of eachmonomer contributing to each of the
two active sites (Montfort et al., 1990).T4 dCMP hydroxymethylase isalso is a
dimer in its native conformation. Forthymidylate synthase, the inhibitorFdUMP
has been used to understand themechanism of binding of substratesfor the
enzyme. A recent and unexpected observationis the ability of FdUMP, 5-
fluoro-2' deoxyuridine-5'-monophosphate,to be an inhibitor of dCMP
hydroxymethylase, while FdCMP the(the dCMP analog of FdUMP) isnot
(Graves and Hardy, 1992).
For thymidylate synthase earlystudies demonstrated that when
monoglutamylated CH2-H4folatewas used, the ligands bound inan ordered
fashion in which dUMP binds firstfollowed by CH2-H4folate andthat the
H2folate leaves before dTMP ina bi-bi reaction sequence (Lorensonand
Maley, 1967). However, it hadalso been observed thata random component
to the kinetics of ligand bindingcould take place whena polyglutamylated
CH2-H4folate was used (Lu et al.,1984). The binding sites forsubstrate and
cofactor were demonstratedto be independent, as longas the CH2-H4folate is
polyglutamylated, by the abilityto modify the enzyme to preventbinding of
either dUMP or polyglutamylatedCH2-H4folate analogues withoutinterfering
with binding of the other ligand(Galivan and Baugh, 1976;Danenberg and
Danenberg, 1978).
Some evidence suggests that inthymidylate synthase the twoactive sites in
thymidylate synthase reactsequentially (Santi and Danenberg,1984;
Danenberg and Danenberg, 1979).These early findings impliedan25
asymmetry during the binding of substrates withenzymes. Comparison
between the unliganded and substratebound crystal structures of E. coli
thymidylate synthase revealeda large conformational change in theenzyme
when substrate bound (Montfortet al., 1990). The binding site for CH2-H4
folate is formed in large part by thenucleotide, and the dUMP binding siteis
somewhat inaccessible once cofactor isbound.
The thymidylate synthases have beensequenced from a variety of
organisms, free living and parasitic, andhave been shown to havea family of
the most highly conservedsequences for any known group ofenzymes (Perry
et al., 1990). The functions for these highlyconserved regions in the
thymidylate synthases, whichappear not to be directly involved in catalysis,
have not been identified, but Montfortet al. (1990) postulate that theymay be
involved in protein-protein interactionswith other enzymes. The T4 dCMP
hydroxymethylase shares homology withthe thymidylate synthases in its active
site region (Graves and Hardy, 1992).
An unusual feature isseen with the thymidylate synthases fromparasitic
organisms where the thymidylatesynthases are bifunctionalenzymes linked to
dihydrofolate reductase in thesame gene. This bifunctional nature hasbeen
identified in seventeen differentparasites and its functionmay reside in
protecting the labile cofactor. Whythis bifunctionality is exclusive,and so far
universal, to parasitic organisms is stillunknown.26
Protein-Protein Interactions, Enzyme Complexesand Metabolons:
Proteins Reside in a Crowded Environment
The basic goal of enzymology isto purify an enzyme to homogeneity and
study it in an isolated environment wherethe factors affecting its ability to
catalyze a reaction are identified andunderstood. Enzymes involved in
intermediary metabolism have usuallybeen found to be globular proteins
which can be easily solubilized, isolatedand characterized away from other
enzymes of the cell. Studying an enzyme in vitro hasbeen and will continue to
be an immensely powerful tool in determiningthe specific reaction being
catalyzed, determination of the reactionmechanism, and identification of the
metabolic role of the enzyme. Yet purificationand isolation will alwayscarry
the risk that important interactions thatoccur within the cell are missed by
studying the isolated enzymes.
How different is the environmentbetween a purified enzyme andan
enzyme in vivo? The activity of an enzyme isnot only dependent on itsown
kinetic parameters but also by theconcentration of protein that surroundsit.In
vivo the protein concentration isvery high, where often the amount ofwater is
nearly equal to the minimumamount needed to solubilize the proteinpresent.
200 mg/ml of protein isa rough estimate of what an enzyme issurrounded by
in a typical living cell.It has been demonstrated thatthe volume occupied by
proteins affects the activity of otherproteins without directly interactingwith
them (Fulton, 1982). Proteinsare more likely to self-associate and hetro-
associations are more likely to takeplace in an environment crowdedwith
other proteins. An example has beenshown with myoglobin being drivento
form dimers when in thepresence of other proteins. However, highprotein
concentrations do not always stimulatecatalysis. For example,27
glyceraldehyde-3-phosphate dehydrogenase is lessactive in the presence of
other proteins which tend to drive the formationof low activity tetramers (Minton
and Wilf, 1981)
At these high protein concentrations theability to understand and model
metabolic flux rates of given pathways becomesextremely difficult. The high
concentration may allow direct exchange of theintermediate between
enzymes of a pathway without having to allow diffusion of thesubstrate into the
bulk water. The possible advantages ofdirect transfer could include the
protection of labile metabolites, the maintenanceof metabolite concentration
gradients, and faster responses to environmentalchanges. The prevention of
accumulation of intermediatesmay be of particular significance in pathways
where the rate-limiting reaction isnot the first committed step in thesequence
(Friedrich, 1984).
Different Classes of Enzymatic Associations
There are many examples where catalyticsites of a pathway are physically
associated. Having two or multiple catalyticsites of a pathway physically
juxtaposed occurs in several differentpatterns of associations. These patterns
of enzymatic organizationcan be divided into three distinctgroups.
The first group, of which DNA polymeraseI is an appropriate example, is
multifunctional proteins wherea single polypeptide has multiple functions.
Catalytic sites are always maintained withinclose proximity by having the
catalytic domains reside ona single polypeptide chain.
The second group consists of the tightlybound enzyme complexes, which
can be defined as complexes that have stoichiometricamounts of
noncovalently associatedenzymes. Examples of these complexes includethe28
well studied pyruvate dehydrogenase complex,the glycine cleavage system,
and tryptophan synthetase. This organizationrequires assembly of the
complexes and the ability to associate ina functional manner.
The third, and most controversialgroup, consists of enzymes that associate
using weak noncovalent interactions. Thisthird group of loosely bound
enzyme complexes is often difficult to isolate intact. Whilethe first two patterns
can be distinguished by having a distinct physicaldifference, i.e., one
organization is based on a single polypeptidewith multiple catalytic domains
and the other involves multiple polypeptidesassociations, the second and the
third groups are arbitrarily differentiatedby the ease of isolation in intact form.
The differences between in vitrostabilities may not reflect the true intrinsicin
vivo stability of organization.
What determines the strength ofa protein-protein interaction or whether
one is even favorable to form? In order fortwo proteins to associate, they first
must have surfaces that are complementaryto one another (Friedrich, 1984).
Complementarity can be definedas the association of protein surfaces that
share the same van der Waals envelopeover a certain area.
The second requirement for specificassociation of two proteins is the
proper positioning of the polar groups. Foran interaction to occur any charged
side chain that resides within thecomplementary surface area will berequired
to form a salt bridge with an oppositecharged group on the adjacentprotein.
The net contribution of the formationof a salt bridge on the freeenergy of
binding, -4 to -13 kJ/mole, is smalland would not seem to bea prerequisite for
protein-protein interaction. The requirementfor salt bridges arises due to the
fact that without their formationa positive charge would have to transfer from
the surface to a hydrophobicenvironment. This transfer would bevery
energetically unfavorable, +40 kJ/molefor each charge that isnot canceled by29
formation of a salt bridge (Friedrich, 1984).In the same vein the number of
hydrogen bonds formed between thecomplementary surfaces should not be
less than the number that the interactingsurfaces could form by themselves
with water.
The Deoxynucleoside TriphosphateSynthetase Complex
For the past twenty yearsa body of evidence has been collected byseveral
research groups, includingour own, which support the idea that the
bacteriophage T4 employsa weakly associated multienzyme complexto carry
out dNTP synthesis. This organizationof deoxyribonucleotide biosynthesis
enzymes is postulated to increase the localconcentration of dNTPs at sites of
DNA replication.
One of the first indications of theexistence of the dNTP synthetasecomplex
in bacteriophage T4was the recognition that the thymidylatesynthase and
dCMP hydroxymethylase intracellularactivity was delayed in theinfected cell
relative to synthesisi of therespective proteins (Tomich et al.,1974). The
estimated reaction flux at early timepoints in vivo for bothenzymes was found
to be low even though the activeenzymes could be isolated at these earlytime
points. The delay was attributedto the time needed for assemblyof the two
enzymes into a multienzyme complex.
Other early evidence involvedthe study of permeabilizedT4-infected
bacteria. T4 containing defectsin their ability to synthesizehm-dCTP were
allowed to infect permeablizedcells with exogenous hm-dCTPpresent. The
surprising finding was that theaddition of hm-dCTP wouldnot bypass the
defect (Wovcha et al., 1973, andNorth et al., 1976). Mutationsin either the T4
phage genes encoding eitherdCMP hydroxymethylaseor dNMP kinase could
not be bypassed by the additionof exogenous hm-dCTP.This led to the30
proposal that a link, physical or kinetic, existedbetween deoxyribonucleotide
metabolism and DNA replication. The further study ofpermeabilized T4-
infected E. coli demonstrated that the incorporation ofeither exogenous
deoxyribonucleoside monophosphatesor ribonucleoside diphosphates into T4
DNA was threefold higher than the incorporationof the deoxyribonucleoside
triphosphate (Reddy and Mathews, 1978).
More direct evidence for the complexwas obtained by looking at the kinetic
linkage of aggregated dNTP-biosynthesisenzymes. Experiments
demonstrated that it was possible to show kineticcoupling by the criterion of
reduced accumulation of intermediates, for thethree enzymes thymidylate
synthase, dNMP kinase, and NDP kinase (Reddyand Mathews, 1978). An
interesting observation made by Mathewswas that the coupling requires
functional dCMP hydroxymethylase,even though the dCMP hydroxymethylase
is not part of the reactionsequence.
The enzyme dCMP hydroxymethylasewas further shown to be required for
the functional complex by mutationanalysis. By examining the kinetic coupling
of bacteriophages which containedC-terminal truncations in their dCMP
hydroxymethylase enzymes it was shownthat dCMP hydroxymethylase
mutants which were less than half the size ofthe full length proteinwere
unable to kinetically couple the threestep pathway
dCTPdCMPdUMPdTMP. It was also shown in thesame studies that
a nearly full length deletion, while enzymaticallyinactive, could still function in
the assembly of the complex by the criterionof kinetic coupling (Thy len and
Mathews, 1989).
A number of attempt have been madeat purification of the dNTP synthetase
complex. Early work indicated that theinteractions between theenzymes were31
weak and easily dissociated. Thefirst attempts at purification of the dNTP
complex were attempted by Chiuet al. (1982) and Allen et al. (1983),and
showed only low level enrichment ofthe dNTP enzymes. These firstattempts
did not confirm the physical linkageof the enzymes.
Through the knowledge gained fromthe earlier studies, Moen et al.(1988)
were able to isolate a highly enrichedpreparation of the multienzyme complex.
The complex was found to dissociatewhen in the presence of high
concentrations of NaCI or MgCl2. Theoverall recovery of the coupledactivity
was low, either reflecting loss during thepurification or a reflection of thein
vivo proportions of complexedverus free enzymes. Experiments with T4
mutants showed that the deoxycytidylatedeaminase, both subunits of
ribonucleotide reductase, and thegene product encoded by regAwere
required to retain the physicalintegrity of the dNTP complex.Finally no DNA
polymerase or other replicationproteins were isolated in thispreparation. The
essential role of the RegA proteinwas an unexpected result of the study.
Translational Regulation ofDeoxyribonucleotide MetabolismEnzymes by
RegA:
While the bacteriophage T4 dCMPhydroxymethylase and thymidylate
synthase enzymes do share homologyin structure and function, theregulation
of their synthesis is quite different.The dCMP hydroxymethylasemessenger
RNA, but not thymidylate synthasemessenger RNA, belongs to a class ofearly
mRNAs that is regulated by theT4 gene product regA.
Since the early 1960s it hadbeen recognized that duringa T-even
bacteriophage infection the synthesisof many early proteinsceased at 12
minutes in a wild-type infection(Dirksen et al., 1960). However,it was32
observed that the early mRNA specieswere still present later in the infection
(Hall et al., 1964). The 12-minutesshutoff could be removed by blockingDNA
synthesis, and in a DNA' mutation theearly gene products werenow
synthesized until 20 minutes, when theywere again shutoff. The 12-minute
shutoff was termed S1, first shutoff,while the 20 minute shutoffwas named S2.
A mutation in bacteriophage T4was later identified that allowed synthesis
of early gene products past theS2 shutoff (Wiberg et al., 1973).This mutation
was within a new gene, regA, whichwas determined to be a translational
regulator of a number of early T4genes. The T4 regA gene was determined
to reside within a cluster of essentialgenes that encode DNA replication
enzymes. Defects in the regA gene, however,cause no adverse effects on
phage DNA replication.
The regA protein inhibits thetranslation of the regulated mRNAsat the
level of initiation, by being ableto compete with ribosomes forbinding to the
translational initiation region of thetarget mRNAs (Winter et al., 1987).The
regA protein is also subjectto autogenous regulation, similarto two other
bacteriophage T4 enzymes, gp32,a single stranded binding protein,and
gp43, the DNA polymerase (Andrakeet al., 1988).
The regulatory effect thatRegA protein has on other T4gene products
appears to be quite complex (Table 1-2).While a number of earlyenzymes are
believed to be down regulatedby the regA gene product,a number of early
enzymes appear to be unaffected by thepresence of the RegA protein anda
minority of enzymesmay be stimulated in their synthesisby the presence of the
transcriptional regulator. Thisstimulation of certain earlyenzymes is believed
to be caused in part by thedecrease in competition for ribosomeinititiation.It
has also been suggested thatthe RegA proteinmay increase gene product
yields by direct interaction withthe messenger RNA (Milleret al., 1987).33
Table 1-2. Effect of the Transcriptional Regulator RegAon Production of T4 Eary Proteins.'
Protein T4 gene_ Effect2
Deoxyribonucleotide Biosynthetic Enzymes
dCMP hydroxymethylase 42
Deoxyribonucleotide kinase 1
dCTPase/dUTPase 56
dCMP deaminase cd
Thioredoxin nrdC
Ribonucleotide reductase, large subunit nrdA 0
Ribonucleotide reductase, small subunit nrdB 0
Thymidylate synthase td +
14 DNA Replication Proteins
DNA topoisomerase subunit 39
DNA topoisomerase subunit 52
DNA polymerase accessory 44
DNA polymerase accessory 45
Single stranded binding protein 32 0
DNA polymerase 43 0to +
DNA helicase 41 +
DNA ligase 30 +
Other Early Proteins
RegA (autogenous control) regA
a-glucosyttransferase a-gt
8-glucosyltransferase 13-gt
DNA-adenine methylase dam
rilA rlIA
rIS rlIB
Lysozyme e
.'The effect thatRegA protein has on the early enzymeswas determined by comparing the
expression of the early enzymes in bacteriophageT4 containing regA- mutationsversus
wild-type infection. An increase in productionof an enzyme when a regA mutation ispresent
is assumed to represent repression of theenzyme in the wild-type infection.
2
-, underproduced; +overproduced; 0, no effect. (Wiberg and Karam,1983)34
It has been estimated that between 10-15% of allthe T4-induced early
proteins are normally under translationalregulation by the regA protein (Miller
et al., 1987). While no additional T4 productsare required for RegA-mediated
translational repression there is evidence that theRegA protein may have
multiple functions and may participate inprotein-protein interactions during the
T4 infection (Miller et al., 1987).
A number of seemingly unrelated propertiesof regA- mutants have been
observed and may represent undescribed functionsof the regA gene product.
One of the first distinctions recognizedbetween the wild type T4 infection and
the regA- infection was that at increasedtemperatures, 43-45°C, regA-
mutants had vastly decreased numbers of viablephage. Surprisingly the DNA
synthetic rates of the regA- mutantswere reduced only by 20% of the normal
wild type rate (Wiberg et al., 1973). Otherobserved characteristics of regA-
mutants included increased sensitivity tohydroxyurea, decreased proteolytic
cleavage of head proteins and partial inhibitionof host DNA breakdown. Work
in our own laboratory using regA-mutants demonstrated that the regAgene
product was necessary for assembly ofkinetically coupled dNTP synthetase
complex (Moen et al., 1988).
The biological role of the regAgene product is still unclear. Past
proposals for the biological role includethe RegA protein binding to siteson
RNA primers for DNA replication andassisting in the formation of the DNA
replisome (Campbell and Gold, 1982). Thisproposal suggested that the
primary binding site for the RegA proteinis to RNA primers on DNA. At early
stages in the bacteriophage infection the RegAprotein would be sequestered,
allowing the deoxyribonucleotideenzymes to be expressed in sufficient
quantities until DNA synthesiswas under way.35
It has also been suggested by Wiberg andKaram (1983) that the RegA
protein may be a component ofa multienzyme complex that couples phage
DNA replication to late transcription andDNA packaging. A final proposal
suggests that the role of the regAgene product is to fine-tune the levels of
enzymes for optimum efficiency (Karam et al., 1982).
In other organized assemblies translationalregulation is used to help
coordinate the assembly of complexes. InE. coil, certain ribosomal proteins
can act as feedback regulators. Excess unassembledribosomal proteins can
feedback repress the synthesis ofnew proteins (Nomura et al., 1977). This
feedback replication while maintainingthe proper ratios of the ribosomal
proteins also minimizes the number ofpartially assembled ribosomes which
could compete and interfere withtranslation in the bacteria.
With this in mind a question aboutthe benefit of having the bacteriophage
T4 enzymes of deoxyribonucleotidesynthesis being arranged ina complex
can be asked.It could be proposed that whileintact and fully functional
complexes would be beneficial to thereplication of the phage, the benefit
could be lost if incomplete and partialcomplexes were also present. By
creating imbalanced pools partiallyassembled complexes would be likely
detrimental and even mutational to thephage replication. Investigatingthe
role of the RegA protein with thedNTP complex may lead toan understanding
on how proper assembly of the complex ismaintained and incomplete
assemblies are kept to a low level.36
Present Work
If the dNTP synthetase complexcan kinetically channel intermediates it
must have a structural arrangement of thecomponent enzymes. A difficult
problem with studying the interactions ofa complex that is supposed to contain
a large collection of different components is differentiatinga direct interaction
of two components of the complexversus the indirect interactions, or
"piggybacking". The goal of my researchwas to develop techniques to identify
enzymes that are directly interacting within the dNTP synthetasecomplex.
Once an initial identification ofa possible direct interaction had beenseen, the
goal was to then characterize the interactionand understand it.
Specifically the enzyme dCMP hydroxymethylasewas chosen as a starting
point for the identification of directinteractions. dCMP hydroxymethylasewas
well documented to be a criticalcomponent of the dNTP synthetase complex
and had been previously cloned andantibodies had been generated.
The use of anti-idiotypic antibodieswas an attempt to develop a new
method to look at enzyme-enzymeassociations. While anti-idiotypic
antibodies were well documented inthe field of receptor research little
published data existed on the efficacy instudying enzyme-enzyme
interactions.
A second project with a related themewas involved with the translational
repressor RegA. As shown previously thepresence of RegA is critical for dNTP
synthetase complex formation. Is the roleof RegA in the formation of the
complex an indirect one,or is RegA actively participating in the formationof the
dNTP synthetase complex. To distinguishbetween the two possible
explanations I tried to identify RegAprotein-protein interactions usingtwo37
techniques which in the past have been usedsuccessfully in our lab. The first
technique is enzyme affinity chromatographyinvolving RegA bound to an Affi-
Gel column and the second method is thegeneration of anti-idiotypic
antibodies to RegA protein.38
CHAPTER 2
Interactions Between T4 Phage-Coded DeoxycytidylateHydroxymethylase
and Thymidylate Synthase as Revealed withan Anti-idiotypic Antibody
J. Patrick Young, and Christopher K.Mathews
Summary
Anti-idiotypic antibodies were usedto mimic the binding surface of the T4
bacteriophage deoxycytidylate hydroxymethylaseenzyme, providing an
immunological probe for protein-proteininteractions involving thisenzyme.
Polyclonal dCMP hydroxymethylaseantibodies were affinity purified andused
to generate anti-idiotypic antibodies. Theanti-idiotypic serum
immunoprecipitated two native viral proteins,deoxycytidylate
hydroxymethylase (EC 2.1.2.8) and thymidylatesynthase (EC 2.1.1.45), froma
sonicated detergent-treated extract ofT4-infected E. coll. The anti-anti-dCMP
hydroxymethylase antibodywas found to be specific in binding to the T4
dTMP synthase, with no detectableaffinity for the host dTMP synthase.
Previous work in our laboratory hasdemonstrated the viral dCMP
hydroxymethylase and dTMP synthaseto be associated in a
deoxyribonucleotide synthetaseenzyme complex. Our current approach
using anti-idiotypic antibodiesas probes for protein-protein interactions,and
complementary studies involving dCMPhydroxymethylase enzyme affinity
columns, indicate a direct associationbetween bacteriophage T4 dCMP
hydroxymethylase and dTMP synthase.39
Introduction
Bacteriophage T4 is a large DNA virus,which scavenges
deoxyribonucleotides released by breakingdown the host's DNA, while also
synthesizing its DNA precursors by denovo pathways using virus-encoded
enzymes. For its own protection, the T4 modifiesdeoxycytidine
monophosphate to 5-hydroxymethyldeoxycytidine monophosphate usingan
enzyme, deoxycytidylate hydroxymethylase. The hm-dCMP1incorporated into
viral DNA confers resistanceto the DNA restriction system of thevirus itself
(Warner and Snustad, 1983).
The T4 bacteriophagegenome encodes a variety ofenzymes of nucleotide
biosynthesis, including dCMPhydroxymethylase and dTMP synthase.The
two enzymes carry out similar reactionson pyrimidine deoxyribonucleoside
monophosphates.
The T4 viral enzymes involvedin deoxyribonucleotidesynthesis have
been implicated to reside ina multienzyme complex (Moen et al.,1988; Reddy
et a1.,1977). As shown inour laboratory, a dCMP hydroxymethylaseprotein
affinity column specifically bindsa variety of T4 proteins, including dTMP
synthase (Wheeler et al., 1992).Each enzyme of the complexshould have
specific protein-protein interactionswith its nearest neighbors inthe complex.
Figure 11-1 shows the pathwaysof dNTP biosynthesis in T4infection, with an
indication of the subunit structureof each enzyme. This diagrammay provide
a framework for predicting interactionsamong enzymes catalyzing sequential
reactions.ADP, GDP, CDP, UDP
rNDP reductase
dCDP, dUDP
dUTPase dCTPase
dUMP
dCMP deaminase
dTMOP synthase
dCMD? hydro
dADP, dGDP
dTMP
dNMIP kinase
m-dCDP, dTDP
NDP kinase
dATP, dGTP, hm-dCTP,dTTP
DNAIiymerase
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Figure. 11-1. The Enzymology of Synthesisof Deoxyribonucleotides for T4
DNA. The pyrimidines, dUMP anddCMP, are modified by the additionof a
methyl or hydroxymethylgroup, respectively, at the 5-position. Thenumber of
subunits is represented for eachindividual enzyme. The virus-coded
enzymes are shaded gray. Nucleosidediphosphate kinase, NDP kinase,is
encoded by the host.41
The work of Chiu and Greenbergdemonstrated the ability of T4 to maintaina
2 to 1 ratio of dTMP to hm-dCMPsynthesis flux in vivo overa wide variety of
environmental conditions (Chiu et al., 1977).The synthesis ratio was
determined to match closely the pyrimidinecomposition found in T4 DNA.
The current understanding of invitro feedback control of individualenzymes
does not fully explain this balance ofmodified deoxypyrimidine synthesis.
A problem with the investigation ofspecific protein-protein interactionsin a
complex is the difficulty in distinguishingbetween a direct interaction and
secondary binding, or "piggybacking".The generation and use of anti-idiotypic
antibodies is an attempt to developa tool to identify direct enzyme-enzyme
interactions. The generation ofanti-idiotypic antibodies alsomay help to
identify intramolecular subunitinteractions, since most or all of theenzymes
involved are oligomeric,as shown in (Figure 11-1).
Anti-idiotypic antibodies have beenshown to mimic the binding specificityof
the original antigen (Figure 11-2).Receptors for morphine, insulin,beta-
adrenergic agonists, acetylcholine,and renal mineralocorticoid have allbeen
successfully studied by using anti-idiotypicantibodies (Schulz and Gransch,
1984; Schulz and Gransch, 1985;Gransch et al., 1988; Lombeset al., 1990; for
review, see Venter et al., 1984).Anti-idiotypic antibodies have alsobeen used
to study structural similaritiesamong enzyme pterin binding sites (Jenningsand
Cotton, 1990) and an intracellularmembrane protein that recognizesa
mammalian endoplasmic reticulumretention signal (Vaux et al., 1990).
Somerville et al. have recentlystudied protein-protein associationsinvolving
the E. coli trp repressor by usinganti-idiotypic antibodies as probeson
immunoblots (Somerville et al., 1990).The technique seemed promisingas a
tool for exploring T4 bacteriophageprotein-protein interactions. We have
modified their methods by usingthe anti-idiotypic antibodiesto
immunoprecipitate proteins fromsonicated non-denaturingdetergent-treated
extracts of T4-infected cells.Immunize
to Anti-E 1
Analyze
Immunoreactive
Proteins
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Figure 11-2. Use of Anti-idiotypic Antibodies to Identify InteractionBetween
Two Enzymes (El and E2). A polyclonalserum contains a population of
antibodies, which recognize a variety of epitopes. This populationof
antibodies can be used to generate anti-idiotypic antibodies. Certainanti-
idiotypic antibodies may reflect the interaction site for protein-protein
association.43
Materials and Methods
Materials:
The MPL+TDM adjuvant used ingenerating the antibodyresponse was
purchased from RIBI ImmunoChemResearch Inc. Protein A-Sepharosewas
purchased from Pharmacia. Affi-Gel 15was purchased from Bio-Rad
Laboratories. Nitro Screen West immunoblotmembrane was purchased from
NEN Research, Dupont. PurifiedE. coli dTMP synthasewas a gift from J.
Ernest Villafranca, AgouronPharmaceuticals Inc.
Protein Purification:
dCMP hydroxymethylasewas purified and rabbit polyclonal antibodieswere
generated to denatured dCMPhydroxymethylase monomers andto native
dCMP hydroxymethylaseas previously described (Wang, 1989).dCMP
hydroxymethylase antibodieswere purified by 25-50% ammonium sulfate
precipitation, followed by affinitychromatography on a dCMPhydroxymethylase
column, and then Protein A purification.T4 thymidylate synthasewas purified
from pKTd2/MB901as described in previous papers (Belfortet al., 1983; Purohit
and Mathews, 1984)
Antibody Affinity Purification:
For the affinity column dCMPhydroxymethylase was purified from50 grams
(wet weight) of E. coli K38 carryingthe plasmid pT7-42 (Lamm,et al. 1988). A
simplified three-step procedurewas used to purify dCMP hydroxymethylasefor
the affinity column. Thesteps involved streptomycin sulfateand ammonium
sulfate precipitations, a DEAESepharose column, andan FPLC gel exclusion
column (Superose 6, Pharmacia).The purified dCMPhydroxymethylase, 7.244
mg, was incubated with 2 ml of Affi-Gel 15 and theproduct washed 3 times with
Milli Q water and 3 times with 0.1 MMOPS, 250 mM KCI, pH 7.5. Afteran
overnight incubation at 4°C, 200 ill of1 M ethanolamine-HC1, pH 8.0,was
added, and allowed to mix for two hoursand react with the still activegroups on
the Affi-Gel. The Affi-Gel 15was spun down after the two-hour incubation,and
the supernatant was measured forunbound protein. Thiswas found to
represent 0.8 mg of unreactedenzyme. The gel was placed in a 3-ml syringe
and washed with 4 volumes of 1Mglycine-HCI, pH 2.6. This washcontained a
substantial amount of unbound dCMPhydroxymethylase, 18% of the total
incubated.
The ammonium sulfate-precipitateddCMP hydroxymethylase polyclonal
antiserum was resuspended in 0.3volumes of PBS and dialyzedversus three
changes of PBS for 10 hours. Theantiserum was then applied overnightat a
flow rate of 1 ml per minute at 4°Cto the dCMP hydroxymethylase-Affi-Gel.The
column bed was first washed witha PBS solution. A second wash involvinga
solution of 0.1 M boric acid-0.025M Na borate-1 M NaCI-0.1%Tween 20 (v/v),
pH 8.3, was applied ata flow rate of 1 ml per min. The finalelution to remove
the bound antibody was carriedout with 1 M glycine-HCI, pH 2.8,which was
collected in a neutralizing solutionof 1 M Tris base, pH 9.6. Asecond affinity
purification was carried outon a second sample. On the secondpurification the
column was pre-washed with all threebuffers before addition of theantibody.
The second samplewas also bound to a Protein A column,which was
washed and the sample eluted offwith a 0.1 M glycine-HCI, pH2.5, buffer,
followed by neutralization by theaddition of 1/20 (v/v) 1.0 M Tris-HCI,pH 9.6,
solution.
Analysis of Purified Antibody:
To determine if the affinity-purifieddCMP hydroxymethylaseantibody was45
still able to bind antigen,a western blot of dCMP hydroxymethylasewas probed
with the affinity-purified antibody.The immunoblot displayeda band
corresponding to the molecular weight of dCMPhydroxymethylase (Figure 11-3).
A corresponding immunoblot developedwith crude antiserum showed far
higher background staining (datanot shown).
In addition samples of the affinity-purifieddCMP hydroxymethylase antibody
were run on a polyacrylamide gel, which showedthat the antibody had been
purified but a considerable amount ofserum albumin protein was still present in
sample A. Sample A was purifiedfurther with a Protein A column toremove
albumin.
Generation of Anti-idiotypic Antibodies:
One milligram of purified dCMPhydroxymethylase antibodywas injected into
each of two New Zealand Whiterabbits along with a syntheticadjuvant,
MPL+TDM emulsion. After 4 weeksthe rabbits were individually boostedwith
an additional 1.0 mg of the purified dCMPhydroxymethylase antibody. One
week after the boost a test bleedwas taken and analyzed for signs of antibody
generation. After positive indications ofantibody production, a major bleed,40
mis, was carried out on each of thetwo rabbits the following week. Beforethe
injection of dCMP hydroxymethylaseantibody the two rabbitswere bled, 10 ml
each, for control pre-immune rabbitserum.
Immunoprecipitation with Anti-(dCMPHydroxymethylase Antibody) Serum:
To identify the antibodiesgenerated in the rabbits, immunoprecipitationson
[35S]methionine-labeled T4-infectedand uninfected E. coil sampleswere
carried out. Pre-immuneserum was used as a control to confirmthat the
proteins precipitated were dueto antibodies generated by theinjection of
dCMP hydroxymethylase antibody.MW HM
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Figure. 11-3. Analysis of the Affinity-purifieddCMP Hydroxymethylase
Antibody. An immunoblotwas carried out with 51.19 protein froman
unfractionated extract of pT7-42/K38 whichhad been induced tooverexpress
dCMP hydroxymethylase. A 12%polyacrylamide gel was run and the
proteins were transferred to NitroScreen.The immunoblot was probed with
affinity purified hydroxymethylaseantibody, 0.5 gg (total protein) ata
concentration of 100 ng/ml.47
T4 and E. coli proteinswere labeled by incorporation of [35S]methionine
in a growing culture. The T4-infectedculture was labeled from 3 to 8minutes
post infection. The E. coli sampleswere labeled for 20 minutes. The
samples were sonicated and unlessotherwise stated treated with DNase1 10
pg/m1 and micrococcal nuclease3 µg/m1 as described previously(Wheeler et
al., 1992). Immunoprecipitationswere carried out in NP-40 buffer: 150 mM
NaCI, 1.0% NP-40, 50 mM Tris-HCI,pH 8.0. The sera and labeledextracts
were incubated at 4°C, 100 gl of Protein Abeads were added and incubation
continued for two hours. The ProteinA beads were washed threetimes by
resuspension in 1 ml of NP-40 buffer,followed by centrifugation. Eachone-ml
aliquot of NP-40 was allowed to sitfor 10 minutes betweencentrifugations. 20
ill of 4x loading buffer--40%glycerol-4% SDS-4% 2- mercaptoethanol-0.5 M
Tris-HCI, pH 6.8--was added andthe samples were heatedat 80°C for 15
minutes. The sampleswere run on polyacrylamide gels, andtreated with 1 M
sodium salicylate, dried and placedover film.
The immunoprecipitationsusing crude serum showedwide variation in
background levels. Overnightincubations of sera with labelledextracts
precipitated a greater amount ofantigen but also increasedthe number and
intensity of background bands.Changes in intensity and numberof
background bands were alsoseen with different T4 infected extracts.
Immunoprecipitations with PBSpresent (Figure 11-6) appearedto decrease the
background signal.
Separation of Antibodies in theAnti-idiotypic Serum:
A 100-g1 aliquot ofserum A was placed on a dCMPhydroxymethylase
affinity column with 5 ml of PBS.The PBS serum solutionwas circulated over
the column for 3 hrs. After 3 hrsthe PBS solutionwas collected and 5 mi of
additional PBS was added to thecolumn and washed through.This PBS48
fraction was concentrated down to 1 ml; it containedthe antibodies that had
no affinity for dCMP hydroxymethylase. Toremove antibodies that did have
an affinity for the bound dCMP hydroxymethylase protein, 5ml of 100 mM
glycine, pH 2.5, was added to the column andcirculated for 1 hr. The acidic
solution was then collected, and the columnwas washed with an additional 5
ml of the glycine buffer. This solutionwas neutralized with 1/20 vol of 1 M
potassium phosphate, pH 8.0. The second washwas then concentrated to
700 IA A 1/10th volume of 10X NP40buffer and also [35Sjmethionine-
labeled T4 extracts, 300were then added to 100 III serum, to thenon-
dCMP hydroxymethylase-bound fraction,and to the dCMP hydroxymethylase-
bound fraction. An immunoprecipitationwas then carried out on the three
samples.
Results
Generation of isologous anti-idiotypicantibodies was attempted with the
purified rabbit anti-dCMP hydroxymethylaseantibody. The cross-
immunization between animals of thesame species carried the benefit of
decreasing the number of antibodiesgenerated to the constant regions of the
hydroxymethylase antibody.
The reasons for use of affinitychromatographic purificationwere 1) the
likelihood that the anti-dCMP hydroxymethylaseantibody is very non-
immunogenic, creating a need to injectthe maximum amount of anti-dCMP
hydroxymethylase-specific antibody, 2) the likelihoodthat dCMP
hydroxymethylase-specific antibody comprisedless than 10% of the total
concentration of antibody found in theserum (Harlow and Lane1988), and 3)
the desire to inject antibodies thatbound only to the surface featuresof native49
dCMP hydroxymethylase. Presumably,these antibodies would be enriched
among proteins binding to a dCMP hydroxymethylasecolumn. The latter
property is sought to maximize thechance of generating antibodiesdirected
against domains involved in protein-proteininteractions.
Immunoprecipitation Using Anti-idiotypicdCMP Hydroxymethylase Serum:
NP-40 buffer was selected for theimmunoprecipitations to allow
separation of proteins from complexeswith minimal disruption of thenative
structure of the proteins.It was also assumed thatnonspecific cross-reactive
epitopes would be minimized whenthe E. coli and T4 proteinswere kept in
the native conformation.
Under these conditionsserum A was found to immunoprecipitate
specifically two viral proteins (Figure11-4). The proteins hadapparent
molecular weights of 28 kDa and32 kDa, respectively. Also sixE. coli
proteins were immunoprecipitatedby serum A. Both theaffinity-purified dCMP
hydroxymethylase antibody andserum B immunoprecipitateda single 28-kDa
viral protein. Controlimmunoprecipitations using pre-injectedrabbit serum
and [35S1-labelled E. coliproteins were also carriedout and did not reveal
immunoprecipitation of either protein.However, a protein of Mr about34-kDa
immunoprecipitated in both thepre-immunized and immunizedsera.
Immunoprecipitations thatwere carried out with labeledextracts preincubated
with deoxyribonucleaseshowed much lower amountsof the 34-kDa protein.
We have tentatively identifiedthis protein as gp32, the T4single-strand DNA-
binding protein. However becauseit is recognized by thepreimmune serum,
and its precipitationappears to be dependent on thepresence of DNA, the
association seems not to bespecific and we have notpursued it further.MW2 3 4 5 6 7 8
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Figure 11-4. Immunoprecipitation of 35S-LabeledT4 and E. coli Proteins.
Lanes 1 through 5 depict immunoprecipitationsof a 35S-labeled T4-infected
E. coli extract. Lanes 6 and 7are immunoprecipitations of 35S-labeled E.
coil extract. The following antibodieswere used: Lane 1, affinity-purified
dCMP hydroxymethylase antibody;Lane 2, anti-idiotypic-dCMP
hydroxymethylase serum A; Lane 3,anti-idiotypic-dCMP hydroxymethylase
serum B; Lane 4, pre-immuneserum A; Lane 5, pre-immune serum B; Lane
6, anti-idiotypic dCMP hydroxymethylaseserum A; Lane 7, anti-idiotypic
dCMP hydroxymethylaseserum B.51
Identification of ImmunoprecipitatedProteins as dCMP Hydroxymethylase
and dTMP Synthase:
Serum A was determined toimmunoprecipitate dCMP hydroxymethylase
and T4 dTMP synthase. Theidentification of dTMP synthasewas confirmed by
the ability of excess purified T4dTMP synthase to inhibit, bydilution, the
immunoprecipitation of the 32-kDa band(Figure 11-5). The addition ofan excess
amount of nonradioactive dCMPhydroxymethylase in comparablefashion was
also specific for extinguishingthe 28-kDa band. Purified T4dTMP synthase
and dCMP hydroxymethylasewere also found to co-migrate with the32-kDa
and 28-kDa bands, respectively,under similar conditions ofelectrophoresis.
The labelled extracts in thisexperiment were not treated with
deoxyribonuclease. Theappearance of the 34-kDa bandwas not affected by
either the addition ofexcess nonradioactive dCMP hydroxymethylaseor T4
dTMP synthase.
The Generated dTMP SynthaseAntibody is not a dCMPHydroxymethylase
Antibody:
T4 dTMP synthase and dCMPhydroxymethylase sharesome sequence
homology (Lamm et al., 1988).Therefore, we had to considerthe possibility
that recognition of both proteinsby one antiserum representedimmunological
cross-reactivity, and that bothproteins were recognizing thesame antibodies.
This possibility was conclusivelyruled out by fractionatingthe antibodies ona
dCMP hydroxymethylase affinitycolumn. As seen in Figure11-6, a dCMP
hydroxymethylase-specific antibody isretained by the dCMPhydroxymethylase
column, while the dTMP synthaseantibody is eluted. The dTMPsynthase-
specific antibody hasno affinity for bound dCMP hydroxymethylaseand
therefore is not a cross-reactivedCMP hydroxymethylaseantibody. In other
words, dTMP synthase anddCMP hydroxymethylaseare recognizing distinct
antibodies in anti-anti-hydroxymethylaseserum A.43 k
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Figure 11-5.Identification of 32-kDa Bandas T4 dTMP Synthase. Lanes 1, 2,
and 3 depict immunoprecipitations ofa 35S-labeled T4-infected E. coli
extract that was not deoxyribonucleasetreated. Lane 1 representsan
immunoprecipitation using serum A. Lane2 represents an immuno-
precipitation using serum A in thepresence of 4014 unlabeled T4 dTMP
synthase. Lane 3 representsan immunoprecipitation using serum A in the
presence of 40 pg dCMP hydroxymethylase. Lanes4 and 5 are Coomassie
blue-stained dCMP hydroxymethylaseand T4 dTMP synthase, respectively.
The outer (unnumbered) lanes depictmolecular weight markers.53
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Figure 11-6.Distinct Anti-dTMP Synthase and Anti-dCMPHydroxymethylase
Antibodies in the Anti-idiotypic Serum. Serum Awas bound to a dCMP
hydroxymethylase-Affi-Gel column and eluted off. Lanes1, 2, and 3 depict
immunoprecipitations of an 35S-labelled T4-infectedE. coil extract. Lane 1,
immunoprecipitation with crude serum A. Lane 2,immunoprecipitation with
the serum A fraction that had affinity fora dCMP hydroxymethylase-Affi-Gel
column. Lane 3, immunoprecipitation with theserum A fraction that had
passed through a dCMP hydroxymethylase-Affi-Gelcolumn.54
The dTMP Synthase Antibody is Specificfor the Bacteriophage T4 Protein:
If the dTMP synthase antibody ismimicking part of the dCMP
hydroxymethylase enzyme surface thatparticipates in a protein-protein
interaction specific for the phage-encodedenzymes, one would expect the
antibody to be also phage-specific.An immunoprecipitationwas carried out
where the antibody's ability to bind 35S-labelledphage dTMP synthasewas
challenged with purified T4 or E. colidTMP synthase (Figure 11-7). Asseen in
previous immunoprecipitations theunlabeled phage-coded dTMPsynthase
could dilute out the 35S-labelledphage dTMP synthase, while the E.coli
dTMP synthase did not inhibit theimmunoprecipitation of the T4enzyme or
any of the E. coli proteins immunoprecipitatedby serum A. The dTMP
synthase antibody binds the phageenzyme and not that of the host.97 k
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Figure 11-7. The Anti-Anti-dCMPHydroxymethylase Antibody is Specific for
Phage-coded dTMP Synthase. Lane 1, T4 proteinsprecipitated by overnight
incubation with anti-anti-hydroxymethylase inthe presence of 20 lag of purified
E. coli dTMP synthase, showing that thebacterial enzyme does not interfere
with the binding between the phageenzyme and the anti-idiotypic serum;
lane 2, E. coli proteins precipitated byanti-anti-HM in the presence of 20
of E. coli dTMP synthase; lane 3, T4proteins precipitated by anti-anti-HM in
the presence of 20 gg of purified T4 dTMPsynthase, confirming that the
labeled 32-kDa band represents T4 dTMPsynthase; lane 4, E. coli proteins
precipitated by anti-anti-HM in thepresence of 2014 of T4 dTMP synthase;
lane 5, proteins precipitated by polyclonalantiserum against T4 dCMP
hydroxymethylase, confirming that the labeled28-kDa protein in lanes 1 and 3
is T4 dCMP hydroxymethylase.56
Discussion
dCMP hydroxymethylase has beenimplicated to reside in a
deoxyribonucleotide synthesis complex, andhas been previously recognized
to interact with other viral proteins when boundto affinity columns. Recent
work has shown that dTMP synthaseis retained on a dCMP
hydroxymethylase protein affinity column alongwith a number of other
bacteriophage T4 enzymes.
The structure of entire protein-antibodycomplexes has been established
for several proteins (Davies et al., 1988).The surface areas were determined
to be large, 500-700 A2. The interactionsites were found to exclude solvent
and were tightly packed. For lysozyme,at a resolution of 2.8 A, no distortion of
either the antibody or proteinwas recognized (Amit et al., 1986).
The ability of an antibody tocover a large surface area of a protein ina
mirror-like image of the protein's surfacesuggests that anti-idiotypic
antibodies to such an antibodymay be able to mimic a portion of the protein's
surface. However, recent workinvolving the determination of thethree-
dimensional structure of an idiotypic-anti-idiotypiccomplex has shown that not
all such complexes indeed containidiotypic mimicry (Bentley et al.,1990). A
number of anti-idiotypic antiseramay have to be generated beforeone is
complementary in structure.
The use of cloned dCMPhydroxymethylase for generation ofantibodies
was advantageous in that antibodiesgenerated later in the project couldnot
possibly have been caused bytrace amounts of T4 protein contaminants
contained in the original purified dCMPhydroxymethylase protein. dCMP
hydroxymethylase is the only T4 proteinpresent in the original extract.
Serum B did not showa dTMP synthase-binding antibody, butdid show a57
large production of dCMP hydroxymethylaseantibody. A possible
explanation for the dCMP hydroxymethylaseantibody seen in both serum
samples is that anti-idiotypic dCMPhydroxymethylase antibodieswere
produced that recognized the dimerbinding site of dCMP hydroxymethylase.
However, we can not rule out thepossibility that the hydroxymethylase
antibodies generated were producedby either dCMP hydroxymethylase
enzyme contamination from the affinity columnor that the dCMP
hydroxymethylase antibody found in thefinal bleeds was from the original
antibody.
An anti-idiotypic antibody thatrecognizes only the phage-encodeddTMP
synthase is indicative of directinteraction between the T4 dCMP
hydroxymethylase and phage dTMPsynthase. Studying the interaction
directly by the use of dCMPhydroxymethylase enzyme affinitycolumns had
shown such an interaction, butdid not answer the questionwhether the dCMP
hydroxymethylase was bound directlyto the phage dTMP synthaseor just
associated with a complex thatcontained dTMP synthase. Thefunction of a
direct association of the twoenzymes could be control of synthesisof modified
deoxypyrimidines. Binding of T4 phagedTMP synthase with dCMP
hydroxymethylase may contributetoward the maintenance ofthe phage
dTMP/hm-dCMP ratio of intracellularsynthetic rates. The determinationthat
dTMP synthase interacts withdCMP hydroxymethylase isthe first evidence
that the arrangement ofenzymes in the T4 deoxyribonucleotidesynthetase
enzyme complex is organized withfunctionally similarenzymes juxtaposed to
one another. Extension of anti-idiotypicantibodies as tools for probing
protein-protein interactionsmay be applicable to further analysisof this
complex and in a variety ofother biochemical systemsthat involve protein-
protein interactions.58
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Footnotes
1 Abbreviations used include: TS,thymidylate synthase; HM, deoxycytidylate
hydroxymethylase; hm-dCMP,5-hydroxymethyl-deoxycytidine 5'-
monophosphate; dNTP, deoxyribonucleoside5'-triphosphate; Tris,
tris(hydroxymethyl)aminomethane; PBS,phosphate-buffered saline, 137 mM
NaCI, 3 mM KCI, 10 mM Na2HPO4,1.8 mM KH2PO4, pH 7.4.59
CHAPTER 3
Protein-Protein Interactions of Purified T4Thymidylate Synthase and dCMP
Hydroxymethylase in vitro
Introduction
Previous studies in our laboratoryhave supported the idea thattwo
homologous bacteriophage T4enzymes, thymidylate synthase, and dCMP
hydroxymethylase, directly interact withinthe deoxyribonucleosidesynthetase
complex. The generation of anti-idiotypicantibodies to dCMP
hydroxymethylase were found toimmunoprecipitate the phage thymidylate
synthase specifically.In addition experiments usingan immobilized dCMP
hydroxymethylase affinity columndemonstrated that the T4 thymidylate
synthase was one of roughlya dozen enzymes that specifically boundto an
immobilized dCMP hydroxymethylaseenzyme (Wheeler et al., 1992).
The unique feature presenton the T4 thymidylate synthase thatinteracts
with the anti-idiotypic antibodyshould also correspond to thethymidylate
synthase domain that forms thejunction with the dCMPhydroxymethylase
enzyme. The generation of thymidylatesynthase C-terminal truncationswere
carried out in an attempt tomap the interaction site of the anti-idiotypicantibody
with the enzyme.
Reconstitution of the protein-proteininteractions that occur betweenthe
enzymes involved in the complex shouldalso prove to be a powerful toolin
understanding the nature of theassociation and its significanceto the synthesis
of deoxyribonucleotides. Tocharacterize the interaction ofthe dCMP
hydroxymethylase with thymidylatesynthase, purification of thetwo enzymes to
homogeneity was carried out, anda number of attempts were madeto study
their binding in an isolatedsystem.60
Materials and Methods
Materials:
The cation exchanger, S-Sepharose,was purchased from Pharmacia. The
E. coli strain AR120 and theoverexpression plasmids pKTd2 andpKTclAl were
gifts from Marlene Belfort. TheS30 cell free transcription/translationsystem
was purchased from Promega Biotec. LBmedium was composed of10 g
Bacto-tryptone, 5 g yeast extract,10 g NaCI 1 ml 1N NaOHper liter.
Mapping the Anti-idiotypic BindingDomain of T4 Thymidylate Synthase:
For the initial attempt atmapping the binding domain of thethymidylate
synthase Exolll deletions of the 3'end of the pkTdAl plasmidwere carried out as
described by Gross and Rohrmann,1990. The plasmid had beenpreviously
been linearized with Hpal andBstXl, restrictionenzymes that cut adjacent to the
3' end of the thymidylate synthasegene. For the generation of deletions 20lig
of the linearized pkTdAl plasmidwas digested at 37°C with 1,258 unitsof Exolll
in at total volume of 60 gl.Aliquots were removed at 30second intervals and
treated with S1 nuclease for 30minutes at 4°C. The deletedplasmids were
ammonium acetate precipitatedand brought up in T4 DNA Pol.buffer. The
ends of the deletionswere polished with T4 DNA polymeraseand the samples
were analyzed on a 1% agarose gel(Figure III-1). Digestionscorresponding to
deletions within the 3' end of thethymidylate synthasegene were recircularized
by T4 ligase and transformedinto the AR120 strain usinga RbCl2 method,
described in Appendix D.
Transformed colonieswere isolated and miniprepswere carried out as,
described in Appendix E,on the individual colonies to confirmthe size of the
deletions (Figure III-2).Inductions of the 3' deletionsalong with the full length
pKTdAl plasmidwere carried out by the addition ofnalidixic acid, 4011g/ml, in
the presence of 10014/mlampicillin and 12ilg/mItetracycline. Polyacrylamide61
gel analysis for expression of theinduced deletions was carried out(Figure III-
3).
In Vitro Transcription/Translationof Thymidylate Synthase:
The expression of thymidylatesynthase was also carried out byusing a cell
free E. coli S30 system. Using theS30 in vitro system expressionof full
length thymidylate synthasewas also found to generate a series of soluble
truncated products. Expression ofa pKTdAI plasmid containing a EcoRV
generated 3' deletion demonstratedthat the truncated formswere C-terminal
deletions, data not shown. Usingthe standard incorporationreaction protocol
the expression of 35S labeledthymidylate synthase was carriedout for 2 hours
at 37°C. Polyacrylamide gel analysisof the labeled thymidylatesynthase with
the truncated productswas carried out alongside an immunoprecipitationof the
products using the anti-idiotypicantibody that recognizes T4thymidylate
synthase (Figure 111-4).
Affinity of Thymidylate SynthaseWith Immobilized dCMPHydroxymethylase:
An initial attemptwas made to look at the interaction of thepurified
thymidylate synthase with immobilizeddCMP hydroxymethylase.For the
experiment, 200 gg of T4 thymidylatesynthase, which had been previously
purified by Linda Wheeler,was dialyzed into 50 mM Tris-acetate,pH 8.0, 25 mM
NaCI, 5 mM MgCl2, 1 mM EDTA,10% glycerol. The thymidylatesynthase was
recirculated through a 5-mg dCMPhydroxymethylase Affi-gel 15 columnat a
flow rate of 1 ml/min for 1 hour.The buffer was collectedand three increasing
NaCI washes, 200 mM, 600 mM,and 2 M, were then recirculatedover the
column at 1 ml/min for 1 houreach. The individual salt washeswere collected
and the amount of thymidylatesynthase present was determinedby Bradford
protein analysis (Figure III-5).4 kb
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Figure III-1. Analysis of Exolll 3' Deletionsof T4 thymidylate Synthase Gene.
The pKTdAl plasmid was linearizedand digested with Exolll nuclease.Aliquots
were removed from the reaction every 30 seconds.The deletions were
analyzed on a 1% agarose gel.A
B
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Figure Analysis of Transformed pKTdAI 3' Deletionsinto a AR120 Strain.
AR120 colonies were selected from the RbCl2transformations of ligated Exolll
digested pKTdAI plasmid and grownup individually in 3 ml LB media. The
plasmids were purified and cut with therestriction enzymes, BamH1 and EcoR1.
The digested plasmids were analysedon a 1% agarose gel. The top gel, (A)
represents the recovered plasmids froma variety of time points. Lane C1
corresponds to the original pKTdAI plasmidcut with BamH1 and EcoR1. Lane
C2 is the original linearized pKTdAI alsocut with BamH1 and EcoR1 restriction
enzymes. Gel (B) represents the various deletion lengthsrecovered from a
single Exolll deletion time point transformation,120 seconds.64
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Figure III-3. Expression of C-terminalTruncated pKTdAl/AR120 Clones.
The original pKTdAl/AR120 constructalong with the Exolll deletions from the90,
and 120 second time pointswere induced with nalidixic acid. The inductions
were sampled at 0, 2, and 10 hours for each constructand analyzed on a
polyacrylamide gel.97 k
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Figure 111-4.Immunoprecipitation of Thymidylate Synthase Truncations.
Lanes 1, 2, and 3 represent the 35S labeled products of the in vitro S30
transcription/translation of the pkTdAl plasmid. Lanes 1 and 2 represent varying
amounts of the full length thymidylate synthase products and C-terminal
truncation products. Lane 3 is an immunoprecipitation of the products using the
dCMP hydroxymethylase anti-idiotypic antibody. Only the full length thymidylate
synthase is immunoprecipitated by the anti-idiotypic antibody.66
Overexpression of lntron and Intron-deletedT4 td Gene:
An initial series of test inductionswere carried out to compare the
overexpression of plasmid encodedbacteriophage thymidylate synthasewith
and without the 1-kbp intronpresent. The test inductions of500 ml-LB cultures
of AR120/pKTd2 (with intron),and AR120/pKTdAl (no intron),were carried out at
37°C in the presence of 100gg/miampicillin and 12 ptg/mItetracycline.The test
inductions were carried out withnalidixic acid, 40 gg/m1 finalconcentration
between an A650 of 0.21 and 0.25.Aliquots were removedat 30 minute
intervals from the cultures andassayed for thymidylate synthaseactivity by using
the Wahba and Friedkin method(1961). Comparisons of theextent of
thymidylate synthase activity inducedand the occurrence ofmaximum activity
were made between the cloned wildtype and intron-deleted tdgene (Figure III-
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Figure III-5.Interaction of Purified T4 Thymidylate Synthase witha dCMP
Hydroxymethylase Affi-Gel 15 Column. The no salt fraction, correspondsto the
original buffer, 50 mM Tris-acetate, pH 8.0, 25 mM NaCI, 5 mM MgCl2, 1mM
EDTA, 10% glycerol. For this initial experiment 200lag of phage thymidylate
synthase was applied to the dCMP hydroxymethylase column. Therecovery of
thymidylate synthase from the salt elutions was 96%.68
Purification of Bacteriophage T4 ThymidylateSynthase:
For a large scale purification ofbacteriophage T4 thymidylate synthase the
intron-deleted overexpression systemwas selected. Eight 500-ml inductions of
AR120/pKtdel were carried out in LBmedium. The 500-m1 cultureswere grown
in 2.5-liter flasks at 37°C in thepresence of 100 p.g /ml ampicillin and 12 gg/m1
tetracycline. Each 500-ml culturewas inoculated with 5 ml of a freshly saturated
overnight culture. The overnight culturewas started from a -80° C glycerol stock
of the AR120/pKtdAl line. Atan A650 nalidixic acid, 40 mg/mlfinal concentration,
was added to each flask and allowed to inducefor 3 hours.
The purification protocol for thebacteriophage T4 thymidylate synthase
involved a modification of the procedurefirst developed by Linda Wheeler.The
frozen bacterial pellet was broughtup in S-Sepharase buffer, 100 ml of 50 mM
KCI, 10 mM B-mercaptoethanol,1mM EDTA, 40 gg/mIPMSF, and50 mM Tris-
HCI, pH 6.5. The samplewas sonicated three times on ice with eachsonication
lasting two minutes. The cell debriswas centrifuged at 10,000 g for 45 minutes.
A 30 to 60% ammonium sulfatecut was carried out at a pH of 7.4. Thepellet
was resuspended in the S-Sepharose bufferwith the addition of fresh PMSF.
The sample was dialyzed overnightin two changes of 4 L S-Sepharosebuffer.
The insoluble materialwas removed by a 10,000 rpm centrifugationin a SS34
rotor.
The supernatant was appliedto a 100-m1 S-Sepharose cationexchange
column at a flow rate of 0.2 ml/min.The absorbance was monitoredat 280 nm
and a gradient elutionwas carried out at a flow rate of 0.5 ml/minafter a
baseline absorbance valuewas attained. The gradientwas composed of an
initial reservoir containing 250ml of 50 mM Tris-HCI, pH 6.5,50 mM KCI, 10 mM
B-mercaptoethanol and a second reservoircontaining 250 ml of 50 mMTris-
HCI, pH 7.5, 350 mM KCI, 10 mMB-mercaptoethanol. Fractionswere collected
and assayed for thymidylate synthaseactivity.1.3
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Figure III-6. Effect of the 1-kbpIntron on Overexpression ofT4 Thymidylate
Synthase. Two separate inductionsof the AR1 20/pKTd2, filledcircles, which
contain an intron within the tdgene were measured along witha single
induction of a similar strain andplasmid which had the intronremoved,
AR1 20/pKtdAl, open circles.70
The cation exchange fractions whichcontained activity were precipitated by
the addition of a 100% saturatedsolution of ammonium sulfate, pH 7.4,to a final
concentration of 70%.
The precipitated proteinwas dissolved in 2 ml of the gel exclusion buffer,50
mM Tris-HCI, pH 7.5, 250 mM KCI,5 mM (3- mercaptoethanol. Thesample was
applied to a Superose 6prep. grade FPLC column at a flow rate of 0.4ml/min.
Fractions were collected and assayedfor thymidylate synthase activity(Figure
III-7). Protein determinations for allthe fractions and the previoussteps in the
purification were carried out using theBradford protein assay. The purified
thymidylate synthase wasrun out on a 12% polyacrylamide gel andCoomassie
blue-stained (Figure III-8). Table III-1summarizes the purification ofthe
bacteriophage T4 thymidylate synthase.
Table III-1.Purification of Bacteriophage T4Thymidylate Synthase
Step in mg Total
Purification Protein
Activity
nmol/min
Specific Activity
nmol/min% of Crude Fold
ActivityPurification mg
Crude Supernatant780 258,000 330 100% 1
Ammonium Sulfate
cut (30-60%)
231 165,262 720 64% 2
Cation Exchange 25 81,900 3,200 32% 10
(S-Sepharose)
FPLC, Gel Exclusion 6 40,908 6,800 16% 21
(Superose 6)S-Sepharose Column
Thymidylate
Synthase
Start
of gradient
71
Figure 111-7.Elution of Phage ThymidylateSynthase From a S-Sepharose
Cation Exchange Column andan FPLC Gel Exclusion Column. The
absorbance was monitored at 280nm. The S-Sepharose column and
Superose 6 gel exclusionwere monitored at 280 nm witha fullscale reading
equal to 2.0 OD units for theS-Sepharose column whilethe gel exclusion
fullscale reading equaled1.0 OD.97k-
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Figure III-8. Polyacrylamide Gel Analysisof Thymidylate Synthase Purification
Steps. Lane 1 represents Coomassieblue-stained crude supernatant. Lane2
represents the ammonium sulfate cut fraction.Lane 3 corresponds to the
collected fractions from the S-Sepharosechromatography. Lane 4 is the
purified T4 thymidylate synthase afterpassage through a FPLC gel-exclusion
column.73
Km and Turnover Determinations forT4Thymidylate Synthase:
The determination of the Km valuesfor the two substrates ofT4thymidylate
synthase, dUMP and 5,10methylenetetrahydrofolate were carried out for
purified enzyme (Figures 111-9, and 111-10).The reactions were carried out ina
buffer volume of 1 ml containing 100mM Tris-HCI, pH7.4, 100mM KCI, 100
mM 13-mercaptoethanol, 25 mM MgCl2,15 mM formaldehyde at 25°C.The
reactions were followed at 338nm for the production of dihydrofolate, AEm=
6,600 L mol-1 cm-1. The concentrationrange of dUMP varied from 218 IIM to
3.6 µM while the5, 10- 5,10methylenetetrahydrofolate varied from 23I.LM to 1.2
RM. The thymidylate synthaseconcentration was 11 nM for allmeasurements.
The concentration ofa dUMP standard was determined bymeasuring the
absorbance at 260 nm at pH 2.0 E= 9,800 mol-1L-1cm-1.
Purification of dCMP Hydroxymethylaseby Low-Affinity Antibody
Chromatography:
The generation of an anti-dCMPhydroxymethylase columnwas carried out
by the initial purification of low affinityanti-dCMP hydroxymethylasepolyclonal
antibodies (Kellogg and Alberts,1992). Figure 111-11 diagramsthe overall
purification scheme. The initialchromatography involvedpassage of anti-
dCMP hydroxymethylase rabbitserum over a 3-ml Affi-gel-10 dCMP
hydroxymethylase column which hadbeen previously used forantibody
purification and protein-proteininteraction studies. A total of10 ml of serum
was loaded onto the column ata flow rate of 1 ml/min at roomtemperature.
The column was washed withTBS, 20 mM Tris-HCI, pH7.5, 0.5M NaCI,
until no protein was detected inthe flow-through. Low affinityanti-dCMP
hydroxymethylase antibodieswere eluted with buffer containing, 1.4M MgC12,
10% glycerol, and 50 mM HEPES,pH7.6.The elution was carriedout by
applying 1-ml aliquots of theelution buffer directly onto thecolumn bed.74
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Figure III-9. The Determination of KmofT4Thymidylate Synthase for dUMP.
Two independent measurementswere carried out for the kinetic determinations.
The second set of velocitymeasurements showed a marked decreasein the
phage thymidylate synthase Vmax,681to533and a slightly decreasedKm,
6.7511Mto6.17 IIM.The averageKmvalue was determined to be 6.5I.M. The
average turnover value was equal to607moles dUMP/molesenzyme
(dimer)/minute.4e+6
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Figure III-10. Determination ofthe Km Value of T4 ThymidylateSynthase for
5,10-Methylene Tetrahydrofolate.Duplicate measurementswere carried out at
each concentration of 5,10methylene tetrahydrofolate A Kmvalue of 43 p.M
was determined for the cofactor. Theturnover number was found to be 912
moles FH2/mole enzyme (dimer)/minute.Using the turnover values forthe
dUMP and cofactor anaverage turnover was determined to be760 ± 152 moles
substrate/mole enzyme (dimer)/minute.Polyclonal Anti -dCMP Y{
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Figure III-11. Schematic for the Purificationof dCMP Hydroxymethylase usinga
Low Affinity Antibody Column. Thecrude extract passagedover the low-affinity
column was 35S-labeled T4-infected E.colilysate. The one step procedure is
advantageous when working with labeledextracts by minimizing the amount of
equipment that comes into contact with theradioactive fractions.77
The elution fractionswere assayed for antibody by Bradford protein
determination. The high affinity dCMPhydroxymethylase antibodieswere
eluted with 100 mM glycine, pH2.2. The eluted fractionswere neutralized with
a 1:20 addition of 1 M phosphate, pH 8.0.
The low-affinity dCMPhydroxymethylase antibodieswere linked to protein
A-Sepharose CI-4B beads byusing dimethylpimelimidateas described by
Harlow and Lane, 1988. A highaffinity dCMP hydroxymethylaseprotein A
column was also made followingsimilar procedures. For eachdCMP
hydroxymethylase column, 250 µl ofprotein A beads were incubatedovernight
at 4°C with the antibody solution in5 ml PBS, 137 mM NaCI,3 mM KCI, 10 mM
Na2HPO4, 1.8 mM KH2PO4,pH 7.4. The protein A beadswere then washed
with 10 volumes of 0.2 M sodiumborate, pH 9.0. The beadswere resuspended
in 5 ml of borate buffer andsolid dimethylpimelimidatewas added to a final
concentration of 20 mM. Thecross-linking reactionwas carried out for 30
minutes at room temperatureand quenched by washing thebeads with 0.2 M
mono-ethanolamine, pH 8.0.
A 500-m1 35S methionine-labeledT4-infected E.coli extractwas prepared
as described before (Wheeler et al.,1992). The labeledextract was brought up
in 6 ml of column buffer, 50mM HEPES, pH 7.6, 50mM KCI, 1.0 mM MgCl2 and
1.0 mM CaCl2. The extractwas sonicated and treated with 10gg/mIDNAse I, 3
gg/mImicrococcal nuclease, anda 1:500 addition of 20 mg /mI PMSFstock
solution. The labeled extractwas centrifuged for 30 minutesat 10,000 rpm in a
SS34 rotor and thesupernatant was collected. Thesupernatant was passed
twice through a 1-ml proteinA-Sepharose column. Thisstep was carried out to
remove proteins that might bindnon-specifically to the protein Acolumn.
The low affinity anti-dCMPhydroxymethylase protein Abeads were washed78
with the final elution buffer, 50 mM HEPES, pH7.6, 1.5 MgC12, and 10 %
glycerol, to remove any uncross-linked antibody.The high affinity anti-dCMP
hydroxymethylase beads were washed with 100 mMglycine, pH 2.2. The
beads were equilibrated in column buffer and placedin 5-ml tubes containing 3
ml of T4-infected extract. The slurrieswere mixed overnight at 4°C in the
presence of protease inhibitor, PMSF.
The immunoaffinity beads were placed in smallcolumns and the extracts
collected. The immunoaffinity columnswere washed 3 times with 5 ml aliquots
of column buffer. To remove associatedproteins from the dCMP
hydroxymethylase enzyme, the columnswere eluted with 0.3-m1 aliquots of
column buffer containing 1.0 M KCI. To elute thedCMP hydroxymethylase
enzyme the low affinity immunoaffinity columnwas washed with 0.3-ml aliquots
of 50 mM HEPES, pH 7.6, 1.5 MgC12,and 10% glycerol. The high affinity
column was eluted with 100 mM glycine, pH2.2. After the elutions a small
sample of both gel matriceswas counted for bound labeled protein. The high
affinity immunoaffinity column retaineda total 120,000 cpm while the low affinity
column had 80,000 cpm attached. Thecollected fractions were counted for
radiolabeled protein (Figure III-12). A 12%polyacrylamide gel was run with the
1.5 M MgCl2 eluted fractions, Coomassiestained, and placed under film (Figure
III-9).
The 1.5 M-eluted dCMP hydroxymethylasewas concentrated in a Centricon-
30 device and brought up in bufferto be used to study the protein-protein
interaction 15 mM potassium glutamate,pH 7.6, 15 mM Mg acetate, 20 mM KCI.
The protein concentration of the purifieddCMP hydroxymethylasewas
determined by carrying out a Bradfordassay. A total of 14.314 of dCMP
hydroxymethylase containing 440,000cpm, 30,600 cpm /µg was purified.120000
100000 -
80000 -
60000 -
40000 -
20000 -
79
0Low-AffinityL
1.0 M KCI
High-Affinity
1.5 M Mg Cl2
fill 1-
0 123456789 10 11 12 13 14 15 16 17 18 19 2021 22 23 24
Fraction Number
Figure III-12. Elution of 35S-Labeled T4Proteins From Low and High Affinity
Anti-dCMP Hydroxymethylase Columns.The two columns were washed with
1.0 M KCl to remove contaminating proteins.The elution of dCMP
hydroxymethylase was carried out by thepassage of 1.5 M MgCl2 over the
columns.80
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Figure III-13. Polyacrylamide Gel Electrophoresisof 35S-Labeled dCMP
Hydroxymethylase. Lane 1 corresponds to thedCMP hydroxymethylase
enzyme eluted with 1.5 M MgCl2 from the low affinity antibodycolumn. Lane 2
represents a 24 hour film exposure of the eluted dCMPhydroxymethylase.81
Results
To more fully understand theinteraction between dCMPhydroxymethylase
and T4 thymidylate synthasean attempt was made to map the anti-idiotypic
binding domain to T4 thymidylatesynthase. The generation of 3'deletions
within the T4 thymidylate synthasegene was carried out. As seen in Figure III-1
the deletion of plasmidsequence using the Exo III nucleasewas quite
controllable. However, the transformantsresulting from these well defined
deletions often gave quite randomlengths for the plasmids within theAR1 20
strain, see Figure III-2, gel A.Several clones were shownto contain deletions
of the correct size for epitopemapping, and were able to beinduced as shown
in Figure III-3. However, thecloned C-terminal deletionswere all determined to
be insoluble, data not shown.
The expression of solubleC-terminal deletions of T4 thymidylatesynthase
was possible using an E. coli S30 in vitrotranscription/translation system. As
shown in Figure III-4,an immunoprecipitation of a mixture offull length and
truncated products showed thatonly the full length proteinwas recognized by
the anti-idiotypic antibody.
An initial experiment to examinethe interaction of thetwo purified enzymes
was carried out involving thepassage of T4 thymidylate synthaseover an
immobilized dCMP hydroxymethylasecolumn. The protocol for thisexperiment
used conditions thatwere similar to previous studiesthat involved thepassage
of crude T4 lysatesover an immobilized dCMP hydroxymethylasecolumn
(Wheeler et al., 1992). In theprevious study the immobilizeddCMP
hydroxymethylase column boundthymidylate synthase specificallyat 0.2 M
NaCI and eluted theenzyme at 0.6 M NaCI. Asseen in figure III-5 the retention
of purified thymidylate synthaseon the dCMP hydroxymethylasecolumn is low
even at 0.2 M NaCI. The significancethat 20% of the thymidylatesynthase was82
initially retained and eluted at 0.2 M NaCIis unclear with this type of affinity
experiment. To try to examine the interactionin a more informativemanner an
attempt was made to study the two proteinsusing analytical affinity
chromatography. Using an equilibrium bindingmethod a member of our lab,
Dr. Wayne Thresher, had previouslyshown that the dissociation constantsfor
macromolecules could be determined byimmobilization of enzymeson
controlled-pore glass. The purification ofthe phage thymidylate synthaseand
35S-labeled dCMP hydroxymethylasewas carried out to initiate such studies.
The bacteriophage T4 thymidylatesynthase gene contains a 1017- base
pair intron (Chu et al., 1984), whichcould affect the overexpression ofthe
enzyme. The bacteriophage introns are relatedto the class I introns found in
certain eukaryotic genes and havebeen shown to self-splice. However,
additional bacteriophagegene products may exist within an infected E.coli
that increase the rate of splicing.The phage thymidylate synthasehas
previously been cloned into severaloverexpression systems which either have
the full length intron presentor have the intron completely deleted (Belfortet al.,
1985 and West et al., 1986). Acomparison of the two systemswas made to
determine if the presence of the intronaffected the degree of induction ofthe
phage thymidylate synthase.
The test inductions as shown inFigure III-6 demonstrate thatthe presence of
the intron did not greatly affectthe expression of the thymidylatesynthase
enzyme. The intron-containing construct surprisinglyshowed a faster induction
of activity than the intron deletedclone. However, the intron-deletedconstruct
did have slightly higher maximuminduction of thymidylate synthaseactivity.
Previous studies by West et al.(1986) had demonstratedno difference in the
time of expression for the twoplasmids, and they madeno comparisons on
maximum activities. The differencesthat I observed were small andcould be
due to natural variation in the AR120strain and not an intrinsic effect ofthe td83
intron. The intron-deletedoverexpression plasmid was selectedfor the large
scale induction of thymidylate synthase.
The purification of thymidylatesynthase generally yielded between6 to 10
mg of purified enzyme. The use of cationexchange chromatographywas very
useful in the purification. Thephage thymidylate synthaseshowed a strong
affinity for the cation column andcould be separated from the majorityof E. coil
proteins, see lane 3 Figure 111 -8.
A range of values have beenreported in the past for the Kmvalue of T4
thymidylate synthase, with the thelowest value equaling 20 AM forenzyme
purified from infected E. coli (Capcoet al., 1973). The variation inapparent
steady-state values may be simplydue to differences in theassay conditions
used. The phage thymidylatesynthase has also been foundto be sensitive to
storage conditions and is easilydenatured. In the past multiplepurification
steps were required for the purificationof the enzyme from infected E.coli
extracts. The intrinsic instability ofthe thymidylate synthasemay also play a
role in the wide variations inthe steady-state values.
The determination of the Kmvalues from the overexpressedphage
thymidylate synthase,as shown in Figures III-9 and III-10,were lower than
previously observed. Theaverage Km value was determinedto be 6.5 AM for
dUMP and 43 AM for 5,10-methylenetetrahydrofolate. Themeasure of enzyme
efficiency, kcat/Km, for T4 thymidylatesynthase was determinedto be 1.6 x 106
(s-1)(mol/L)-1 while dCMPhydroxymethylase has a kcat/Kmthat is only 7.6 x
103 (s-1)(mol/L)-1(Pizerand Cohen, 1962).
The study of the interactionsof the two enzymes byanalytical affinity
chromatography involves themeasurement of the mobilemacromolecule over a
wide range of concentrations.To study the interactionat low dCMP
hydroxymethylase concentrationsthe generation of 35Slabeled dCMP84
hydroxymethylase was attempted. Aone step purification of the labeled dCMP
hydroxymethylase enzyme was attemptedby using a novel chromatography
method described by Kellogg andAlberts (1992), which involves purificationof
enzymes by generation of a low-affinity antibodycolumn which elutes purified
protein under non-denaturing conditions.As shown in Figure 111-12, the elution
of radioactive proteinwas seen when a low-affinity antibody columnwas
washed with 1.5 M MgCl2. A columncomposed of high-affinity anti-dCMP
antibodies was constructedas a comparison control. Surprisingly the high
affinity antibody column did not elutethe dCMP hydroxymethylaseenzyme
even at pH 2.2. Figure III-13 demonstratesthat the eluted dCMP
hydroxymethylase was highly purified.
For an initial attempt touse the two proteins in an analytical affinity
experiment 6 mg of the purifiedthymidylate synthase was coupledto controlled-
pore silica beads as described previously(Thresher and Swaisgood, 1990).
After coupling, the immobilizedthymidylate synthase was determinedto be
highly active. However, theimmobilized enzyme was determinedto be
unstable and was found to losea majority of activity during a set of control
experiments.
Discussion
The generation of 3' deletionswithin the plasmid encoded T4thymidylate
synthase gene failed tomap the epitope binding domain of thedCMP anti-
idiotypic antibody. The overexpressionof truncated thymidylatesynthase within
a AR120 E. coil strain generated only insolubleprotein. However, the in vitro
generation of soluble thymidylatesynthase truncationswas successful. The
inablility of the truncationsto be immunoprecipitated by theanti-idiotypic
antibody demonstrates that theC-terminal region is requiredfor binding. These
results indicate that either theanti-idiotypic antibody bindsto the C-terminal end
of the thymidylate synthase,or that the C-terminal section isrequired for the85
proper folding of the protein-protein interactiondomain which resides
elsewhere on the thymidylate synthase.
An initial study demonstrated thatpurified thymidylate synthaseappears to
have lower affinity for immobilizeddCMP hydroxymethylase thanthymidylate
synthase in a crude extract. Whilethe discrepancy seen in thetwo experiments
may be caused by the different buffers usedin the affinity experiments, other
possible explanations include thepossibility that molecular crowdingin the
lysate experiments increases theaffinity of thymidylate synthase fordCMP
hydroxymethylase, or that the interactionbetween thymidylate synthase and
dCMP hydroxymethylase is stabilizedby other proteins that interactwith the
immobilized dCMP hydroxymethylase.
The comparison of theoverexpression of intron deletedthymidylate
synthase with the wild typegene demonstrated no time inductionlag with the
intron-containing gene and in fact theinduction of the intron containingplasmid
was faster than the intron-deleted plasmid.A slightly higher overallinduction of
activity was seen with the intron-deletedgene.
Finally, we extend the demonstratedversatility of the low-affinityantibody
method for purification ofenzymes from T4-infected extracts.86
CHAPTER 4
Investigation of Protein-ProteinInteractions Involving RegA UsingAnti-idiotypic
Antibodies and Protein Affinity Columns.
Introduction
Soon after the infection of E.coil by bacteriophage T4 rapidtranscription of
the phage genomeoccurs within the host cell. During the25-minute T4
reproductive cycle both transcriptionaland translational regulationoccurs
within the infected E. coll. TheregA gene product isa small protein of 15kDa
which is known to actas a translational regulator of at least12 T4 early and
middle T4 genes (Websteret al., 1989). The levels of RegAprotein in the
infected cell are also translationallyautoregulated, and the protein ispresent at
low levels, 1.5 to 7.5 I.LM (Milleret al, 1985).
The RegA proteinrepresses translation through occlusionof a portion of the
mRNA sequence recognizedby the ribosome duringtranslation initiation
(Gold, 1988).It has been demonstratedin a plasmid-encoded regAsystem
that the regA-mediated translationalrepression requiresno other T4 products
(Miller et al., 1987).RegA-sensitive mRNAs haveneither a common secondary
structure nor sequence homologyat the binding site. Many ofthe mRNAs
which are targets do containa uridine-rich area at the translationinitiation site.
However, the position andamount of uridine varies greatlyamong transcripts.
Work from this laboratoryand others has demonstratedthat bacteriophage
T4 employs a multienzymecomplex to synthesizedeoxyribonucleotides.
Experiments with T4 mutantsdemonstrated that the regAgene product is
necessary to retain kinetic and physicalintegrity of this complex(Moen et al.,
1988).87
Why is the regA gene productnecessary for the formation of the dNTP
complex? We have proposed that eitherthe regA gene product interacts
directly with the complex asan integral member of the complexor interacts
through protein-protein interactionsduring the assembly.
A second possible explanationis that the regA gene productdoes not
directly interact with the dNTP complexbut instead is involved in coordinating
the stoichometric levels of the individualenzymes of the complex at theproper
concentrations to allow proper association.To determine which of thetwo
possible proposals is correctwe have set out in this study to determinewhether
the RegA protein is interacting withany other T4 or E. coli proteins.
Two methods which have beenused successfully in thepast in our lab to
identify protein-protein interactionswere carried out to identify any possible
associations of dNTP biosynthesisenzymes with the RegA protein. The first
method involved immobilizationof RegA protein ontoan agarose matrix and
using it for affinity chromatographyof lysates of [35S] methionine-labeledT4-
infected E. coli extracts. A secondcomplementary method to identifyprotein-
protein interactions involvedthe attempt to generateanti-idiotypic antibodies to
the RegA protein. The anti-idiotypicantibodies would serveas immunological
mimics of the RegA protein bindingdomains, and allow the identificationof
protein-protein interactions.
Materials and Methods
Materials:
The MPL+TDM adjuvant usedin generating the antibodyresponse in
rabbits was purchased fromRIBI ImmunoChem ResearchInc. Freund's88
complete adjuvant was purchased from Sigma.Protein A-Sepharose was
purchased from Pharmacia. Affi-Gel 15was purchased from Bio-Rad
Laboratories. Nitro Screen West immunoblotmembrane was purchased from
NEN Research, Dupont. RegA proteinused for these experimentswas a
generous gift from Drs. William Konigsberg and EleanorSpicer. For the control
bovine serum albumin (BSA), affinity column,1.2 mg fraction V-protease free,
was purchased from Sigma.
Preparation of a RegA Affinity Column:
RegA, 1.93 mg, was dialyzed overnightin a coupling buffer consisting of
300 mM NaCI, 100 mM MOPS, pH 7.5.The RegA protein was then
concentrated to 1200 ill after dialysis. A400111 slurry of Affi-Gel 15was thawed
and washed at 4°C with 5 ml waterfollowed by 5 ml coupling buffer. Thegel
slurry was incubated with the RegAprotein for 4 hours at 4°Con a rotating
platform. The Affi-Gel reactivegroup was quenched with 25 IA of 1 M
monoethanolamine, pH 8.0. The amountof uncoupled proteinwas determined
by a Bradford protein assay. Thecoupling efficiency was determinedto be
66%, yielding a RegA protein affinitycolumn with 1.27 mg of boundprotein.
Generation of Rabbit Anti-RegA PolyclonalAntibodies:
For the generation of the initialanti-RegA antibody, two femaleNew
Zealand White rabbitswere each injected at an intramuscular sitewith 800 ilg
of native RegA protein. The RegAprotein had been previouslydialyzed into
PBS, concentrated to 1 mg/ml,and vortexed with an equalvolume of
MPL+TDM synthetic adjuvant. After4 weeks the rabbitswere boosted with an
additional 800 gg RegA. Two weeksfollowing the booster injectionscardiac89
punctures were carried out and 30 ml of bloodwas collected from each rabbit.
A second bleed was carriedout two weeks after the initial bleed. Noadditional
boosting with RegA proteinwas carried out between the two collections.
An immunoblot was carriedout to determine whether anti-RegAantibodies
had been generated (Figure IV-1).As determined by the immuno-blot,both
rabbits had generated anti-RegAantibodies, with rabbit B apparentlygiving a
larger response to the RegA injections.The crude sera showed high
backgrounds when incubated withT4-infected E. coil extracts.
Purification of Anti-RegA Antibody:
The first step in purification of theanti-RegA antibodies waspassage of the
crude sera over a protein A-SepharoseCI-4B column (Harlow andLane,
1988). Before the protein Apurification, 4.5 ml ofserum was thawed and
centrifuged 15,000 g for 15 minutesand then a 1:10 volume of 1 M Tris,pH 8.0
was added. The serum was passedover a 2-ml protein A-Sepharose CI-4B
column. The column was washedwith 10 volumes of 10 mM Tris,pH 8.0. The
rabbit IgG was eluted with 100mM glycine, pH 3.0, andten 1.5-m1 fractions
were collected. The glycine bufferwas neutralized by the addition of 100111of
1 M Tris, pH 8.0. Bradfordprotein assays were carriedout to identify the
fractions containing IgG.
The protein A columnwas found to be quite stable, and thepurification of
30 ml serum from rabbit Bwas carried out by repeatedpassage of serum
samples over the protein A column.After purification of rabbit Bserum the
column was washed with 10column volumes each of 2 Murea, 1 M LiCI, and
finally with 100 mM glycine, pH2.5. Purification of rabbit Aserum was then
carried out as described previously.The typical yield of IgGwas between 1-3
% of the total protein in thecrude serum.90
12 12
43 k-
29 k-
18 k-
RegA 14 k i
Figure IV-1. The Generation of Anti-RegA Antibodies. An immunoblotwas
carried out to determine whether anti-RegA antibodieswere generated in the
two rabbits. A 15% polyacrylamide gel was run and the proteinswere
transferred to NitroScreen. Lanes 1 and 3were loaded with 0.5 lig of purified
RegA protein. Lanes 2 and 4 were loaded with 20lig of crude bacteriophage
T4-infected E. coli extract. The immunoblotwas divided in half and lanes 1
and 2 were incubated with serum A, diluted 1:200, while lanes3 and 4 were
incubated with serum B diluted 1:200. Serum B showed thestronger signal to
RegA and was also cross-reactive to an unidentified 16-kDaprotein.91
The second step in purification ofthe RegA antibodies involvedpassage
over a RegA protein affinity column. Theaffinity purification was carriedout to
separate the anti-RegA antibodies fromthe non-specific IgG protein. ARegA
protein Affi-Gel 15 column whichcontained 1 mg of RegA proteinwas washed
with 5 column volumes of PBS,137 mM NaCI, 3 mM KCI, 10mM Na2HPO4,
1.8 mM KH2PO4, pH 7.4. Foreach affinity purificationrun, 2.3 mg of rabbit IgG
was passaged three times through thecolumn at a flow rate of 0.1 ml/min.The
column was washed with 20 bedvolumes of 4°C PBS. The RegAantibodies
were eluted with a 100-mM glycine wash,pH 2.2. The eluted RegAantibodies
were collected into 1-ml fractions andneutralized with 1 M phosphate pH8.0.
For the affinity purification 7%of the total IgG from rabbitB bound to the RegA
protein column (Figure IV-2).For each 1 ml ofserum from rabbit B roughly 100
gg of purified anti-regA antibodywas recovered. Purification of rabbitA anti-
RegA antibody consistentlyproduced lower yields of thepurified antibody,
approximately 3% of the total IgG.
Papain Digestion of Anti-RegA IgGto Fab Fragments:
For the digestion of anti-RegAto Fab fragments 1:20 volumeof 1 M
cysteine, and EDTA, 1 mM finalconcentration, were added to thepurified anti-
RegA antibodies. Both proteinA-purified RegA antibody andprotein A-purified
plus affinity-purified RegAantibodies were used as substratesto generate Fab
fragments. The antibody hadbeen previously dialyzed into100 mM Na
acetate, pH 5.5, and concentratedto 5 mg/ml. For 1 mg of IgG,10 lig of papain
was added and incubated at 37°C for2 hours (Figure IV-3). Tostop the
digestion a 1:10 addition of 750mM iodoacetamidewas added.MW
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Figure IV-2. Anti-RegA Rabbit Antibody Affinity Purification.
A 13% polyacrylamide gel was run and Coomassie blue-stained containingthe
three collected fractions from the anti-RegA antibody purification. Lane1 was
loaded with 10 lig of the protein-A column flow through. Lane 2was loaded
with 3 jig of the RegA column flow through. Lane 3 contains 3µg of proteinthat
was eluted from the RegA affinity column. An immunoblot was also carried out
with 30 µg of T4-infected E. coil lysate in each of three blots. Each
immunoblot was incubated with an equivalent amount of protein, 0.51.ig (total
protein) at a concentration of 100 ng/ml. Lane 4 was incubated with the
protein-A column flow through. Lane 5 was incubated with the RegAcolumn
flow through, while lane 6 was developed with the protein that boundto the
RegA affinity column. All three immunoblots were developed withequivalent
amounts of alkaline phosphatase secondary antibody.Fab
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Figure IV-3. Generation of Anti-RegA Fab Fragments by Papain Digestion.A
24-hour digestion of anti-RegA rabbit antibodywas carried out and a 10%
polyacrylamide gel was run. Lane 1 contained anti-RegA IgG that had been
digested for 24 hours with papain and was loaded onto the gel in samplebuffer
containing 3-mercaptoethanol. Lane 2 is a similar sample but loadedwithout
13-mercaptoethanol. Lane 3 and Lane 4 were loaded with anti-RegA IgGthat
was not treated with the protease.94
Separation of Fab Fragments fromFc Regions:
After digestion of the RegA antibodiesthe fragments were mixed with 2
volumes of PBS and concentrated ina Centricon 30 device. The fragments
were purified by a final passageover a RegA protein affinity columnas
described before for the purification ofthe intact antibody. When proteinA
purified plus affinity purified regA antibodieswere used in the papain digestion
the yield of affinity purified Fabapproached 20% of the initial RegAantibody
concentration (Figure IV-4). When proteinA-purified RegA antibodywas
digested and purified the yieldwas less than 1c/0 of the initial antibody protein
concentration.
Generation of Mouse Anti-idiotypicAntibodies:
For the generation of anti-idiotypicantibodies Swiss-Webster micewere
injected intraperitoneally with 50lig of affinity-purified RegA Fab (Harlowand
Lane, 1988). The Fab fragmentswere mixed prior to the injection with 9
volumes of complete Freund'sadjuvant. The total volume of theinjected
material was 200 gl. Eachmouse received Fab fragments from onlyone Fab
purification. Fab fragments originatingfrom different rabbitswere not mixed
during the purificationnor during the injections. For each anti-RegAFab isolate
from an individual rabbit, two micewere injected with identical purified Fab.
After 28 days the first booster injectionwas administered by using thesame
protocol as the primary injection.Additional boosts were then carriedout on a
weekly basis.
After three booster injections allmice showed signs of peritonealswelling
but the development of ascitesfluid did not occur. Tail bleedswere carried out
on the mice as an alternative to collectionof ascites fluid. An additionalmouse
which did not receiveany injections was also bled. Finallyas a second control
a mouse was injected and boosted withFreund's complete adjuvantwithout
Fab fragments.Fab -IN-
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Figure IV-4. Affinity Purification of RegAFab Fragments. A 12% polyacrylamide
gel was loaded using sample buffer that didnot contain B-mercaptoethanol.
Lane 1 was loaded with affinity purifiedAnti-RegA Fab fragment whichwas
generated from protein A-purified rabbit A IgG.Lane 2 was loaded with affinity
purified Anti-RegA Fab fragment whichwas generated from both a protein A
column and a RegA affinity column purificationof rabbit B IgG. Lane 3
represents the flow through of the affinity purificationof the anti-RegA Fab from
protein A-purified rabbit A IgG. Lane4 is the flow through of the affinity
purification of the anti-RegA Fab from theprotein A column and a RegA affinity
column purification of rabbit B IgG. Thelast lane contains purified anti-RegA
IgG from rabbit B thatwas not treated with papain.96
Testing for Anti-idiotypic Antibodies:
To test for the generation ofmouse antibodies to the rabbit Fab fragmentsa
preliminary slot blot was carried out afterthe first boost. Anti-RegA Fab
fragments from each rabbit were boundto nitrocellulose along witha non-
specific rabbit Fab as a control. The fulllength anti-RegA IgG from rabbit Aand
rabbit B were also blotted. Finallya crude extract of T4-infected E. coliwas
bound to the nitrocellulose. The slotblots were incubated with thesera of the
anti-RegA Fab challenged mice. Thesecondary anti-mouse alkaline-
phosphatase antibody was then addedto the blots and also placed ina control
blot that had not been incubated witha primary antibody (Table IV-1).
A western immunoblotwas also carried out on the non-specific rabbitFab
and the anti-RegA Fab fragments(Figure IV-5). All the anti-Fabmice sera were
able to stain a band correspondingto the rabbit Fab fragments.Non-specific
rabbit Fab fragment was alsodeveloped by the anti-Fab micesera,
demonstrating that at least part of theimmunogenic response generated inthe
mice was to a conservedarea of the Fab fragments. Mouseserum injected
only with Freund's complete adjuvantdid not develop a bandon the
immunoblots.
After one booster injection anti-rabbitFab sera failed to developa positive
signal against T4 proteins. Twomore additional boosts were carriedout and
immunoprecipitations were then carriedout.97
Table IV-1. Generation of Mouse Antibodiesto Rabbit Fab Fragments.
Mouse injected anti-RegAanti-RegAanti-RegAanti-RegA T4 ProteinsControl Serum antigen Fab A Fab B IgG A IgG B Rabbit Fab
AlRabbit Fab A + +
B1Rabbit Fab B ++ ++
Control, anti- mouse 2°
+++97k-
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43k-
Fab)'-
29k-
18k-
14 k-'
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Figure IV-5. The Generation of Anti-FabAntibodies. An immunoblotwas
carried out to confirm that anti-Fab antibodieswere generated in the mice. A
12% polyacrylamide gelwas run and the proteins were transferred to
NitroScreen. Lanes 1 and 2 of eachimmunoblot was loaded with 0.2lag of
affinity purified RegA Fab fragments. Lane3 for each immunoblotwas loaded
with 0.2 µg of non-specific rabbit Fabfragment. The Fab fragmentswere
loaded onto the gel in sample buffer thatdid not contain 13-mercaptoethanol.
Immunoblot A, B, C, and D were developedwith 1:1000 dilution of A1, A2, Bl,
B2 anti-rabbit Fab mousesera, respectively. Immunoblot E was developed
with 1:1000 dilution of Freund'sinjected mouse serum.99
Immunoprecipitation with Mouse Anti-anti-RegA:
T4 and E. coil proteinswere labeled by incorporation of [35S]methioninein
a growing culture. The T4-infected culturewas labeled from 3 to 8 minutes
post infection. The E. coli sampleswere labeled for 20 minutes. The samples
were sonicated and unless otherwise statedtreated with DNase 110 p.g/m1 and
micrococcal nuclease 3µg /ml as described previously (Wheeleret al., 1992).
Immunoprecipitations were carried out ineither a "mild" NP-40 buffer: 150mM
NaCI, 1.0% NP-40, 50 mM Tris-HCI,pH 8.0 (Figure IV-6 and IV-7)or a more
stringent RIPA buffer: 150 mM NaCI,1.0% NP-40, 0.5% DOC, 0.1%SDS, 50
mM Tris pH 8.0 (Figure IV -8). Thesera and labeled extracts were incubatedat
4°C, 100 pl of Protein A beadswere added and incubation continued fortwo
hours. The Protein A beadswere washed three times by resuspensionin
either 1 ml of NP-40 or RIPA buffer,followed by centrifugation. Eachone-ml
aliquot of buffer was allowedto sit for 10 minutes betweencentrifugations. 20
p.I of 4x loading buffer--40%glycerol-4% SDS-4% 2- mercaptoethanol-0.5 M
Tris-HCI, pH 6.8--was addedand the samples were heatedat 80°C for 15
minutes. The sampleswere run on polyacrylamide gels, andtreated with 1 M
sodium salicylate, dried and placedover film.43 k-
29 k-
18 k-
1 23 4 5 67
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Figure IV-6. Immunoprecipitations in NP-40 Buffer of 35S-Labeled T4 and E.
coli Proteins. Lanes 1 through 3 depict immunoprecipitations of a 35S-labeled
T4-infected E. coli extract. Lanes 4 and 5 are immunoprecipitations of 35S-
labeled E. coli extract. The following antibodies were used: Lane 1, pre-
immune mouse antibody; Lane 2, anti-rabbit Fab (B1) mouse serum; Lane 3,
anti-rabbit Fab (A1) mouse serum; Lane 4, anti-rabbit Fab (B1) mouse serum;
Lane 5, anti-rabbit Fab (A1) mouse serum;Lane 6, 35S-labeled T4-infected
E. coli extract ;Lane 7, 35S-labeled E. coli extract.RegA
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Figure IV-7. Immunoprecipitation in NP-40 Buffer with Anti-RegA Sera, Anti-
rabbit Fab Sera, and Freund's Challenged Mouse Serum. Lanes 1 through 7
depict immunoprecipitations of a 35S-labeled T4-infected E. coli extract. The
following antibodies were used: Lane 1, anti-RegA (A) affinity purified rabbit
IgG; Lane 2, anti-RegA (B) affinity purified rabbit IgG; Lane 3, anti-rabbit Fab
(A1) mouse serum; Lane 4, anti-rabbit Fab (A2)mouse serum; Lane 5, anti-
rabbit Fab (B1) mouse serum; Lane 6, anti-rabbit Fab (B2)mouse serum; Lane
5, anti-rabbit Fab (B1) mouse serum; Lane 6, Freund's injectedmouse serum.200 k-
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Figure IV-8. Immunoprecipitation of 35S-Labeled T4 Proteinsin RIPA Buffer.
Lanes 1 through 8 depict immunoprecipitations ofa 35S-labeled T4-infected E.
coli extract carried out under identical conditionsas done in Figure IV-6, except
that the buffer used was RIPA instead of NP-40.. Thefollowing antibodies were
used: Lane 1, anti-RegA polyclonalserum from Eleanor K. Spicer, Yale
University; Lane 2, anti-RegA (A) affinity purified rabbitIgG; Lane 3, anti-RegA
(B) affinity purified rabbit IgG; Lane 4, anti-rabbitFab (A1) mouse serum; Lane
5, anti-rabbit Fab (A2) mouseserum; Lane 6, anti-rabbit Fab (B1) mouse serum;
Lane 6, anti-rabbit Fab (B2) mouseserum; Lane 7, anti-rabbit Fab (B1) mouse
serum; Lane 8, Freund's injected mouse serum.103
Specific Associations of E. coil and T4proteins with Immobilized RegA:
To examine interactions of boundRegA protein with E. coil and T4proteins
labeled [351 S-methionine extractsof E. coil and T4 infected E. coilwere made
as described previously. The T4-infected culturewas labeled from 3 to 8
minutes post infection, and the E.coil samples were labeled for 20minutes.
Before being passed through the RegAaffinity column, the labeledextracts
were centrifuged at 15,000 g for 5 minutes.A total of 3x106 cpm of labeled
extract was mixed with the RegA Affi-Gelmatrix in 1 ml of column buffer,1mM
EDTA, 1 mM 8-mercaptoethanol,5 mM MgC12, 10 % (WN) glycerol,25 mM
NaCI, 20 mM Tris-HCI, pH 8.0,overnight at 4°C. The RegA matrixwas placed in
a small column and washed with increasingsalt concentrations, 25 mM,200
mM, 600 mM, 2 M NaCI. Foreach salt concentration threesequential washes of
2 ml were carried out witheach 2 ml volume allowed torecirculate for 15
minutes before being drained offand counted for radioactivity.The column was
further washed with 2 M NaCI untilno additional cpm were seen in thewash.
The column was re-equilibratedwith 25 mM NaCI column bufferand the affinity
experiment was repeated usinglabeled E. coil extract
The fractions from the affinityexperiment were placed in scintillationcocktail
and counted for 35S methionine(Figure IV-9). The fractionswere also
concentrated and applied toa 10% polyacrylamide gel. Entire fractionsof each
of the three high salt washes,200 mM, 600 mM, 2 M NaCI,were loaded on the
gel. For the initial low salt wash,25 mM NaCI, only 1 %, 25p,I, of the fraction
was loaded on the gel for both the T4and E. coil extracts (FigureIV-10).
As controls to identify possiblenon-specific interactions theabove
procedure was repeated by passinglabeled T4 extractover a blocked
ethanolamine Affi-Gel 15 columnand a BSA coupled Affi-Gel15 column (Figure
IV-11). The BSA Affi-Gelcolumn contained 1.2mg of coupled BSA to the
matrix.104
Figure IV-9. Percentage TotalRadioactivity of 35S-Labeled T4 and E.coli
Proteins Eluted from Affinity Columns.Aliquots were removed from the three
sequential washes at a given saltelution concentration. The aliquotswere
placed in scintillation cocktail andthe radioactivity determined. Thepercent of
total applied radioactivitywas calculated for the three highest saltwashes 200
mM, 600 mM, 2 M NaCI, for eachof the four affinity experiments; 35S-labeled
T4-proteins bound to a RegA column; 35S-labeledE. coli-proteins bound toa
RegA column; 35S-labeled T4-proteinsto a BSA column; 35S-labeled T4-
proteins to an ethanolamine-blockedAffi-Gel 15 column.0
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Figure IV-10. Analysis of T4 and E. coilProteins Bound to a RegA Affinity
Matrix. Lanes 1-4 depict 35S-labeledT4-proteins that were eluted froma
RegA Affi-Gel 15 column at increasing saltconcentrations 0.025, 0.2, 0.6
and 2 M NaCI, respectively,as described in the Methods section. Lane 1
represents only 1% of the total eluted proteinfrom the first 0.025 M wash.
Lanes 2, 3, and 4 represent the entirefractions for each salt concentration.
Following the final salt wash 20 III of theRegA affinity gel matrix was
removed and boiled in NaDodSO4 samplebuffer and loaded as lane 5.
Lanes 6-9 depict 35S-labeled E. coli proteinsthat were eluted from the
RegA affinity column using identical NaCIconcentrations as in lanes 1-4.
Lane 10 depicts 20 µl of the affinity matrixafter the final salt wash of the E.
coil proteins. The 10% polyacrylamidegel was treated with 1 M sodium
salicylate and placed on film at -70°Cfor 8 days.BSA Control Column
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Figure IV-11. Analysis of T4 Proteins Bound to Control BSAAffi-Gel and
Ethanolamine Affi-Gel Columns. The two control columnswere incubated
with an equivalent amount of 35S-labeled T4-infected E. coilextract as
passed over the RegA affinity column. Lanes 1-4 depict 35S-labeledT4-
proteins that were eluted from a BSA-Affi-Gel 15 columnat increasing NaCI
concentration; lane 1, 0.025 M; lane 2, 0.20 M; lane 3, 0.6 M;lane 4, 2 M
NaCI. The boiled BSA column matrix, lane 5, containsno detectable
protein. Lanes 6-10 depict T4 proteins eluted froman ethanolamine-
blocked Affi-Gel 15 column at increasing NaCI concentrationsas in lanes 1-
4. The boiled ethanolamine Affi-Gel 15 column also hadno detectable T4
proteins, lane 11.108
Results
RegA protein was coupled toan affinity column matrix to answer the
question, does RegA interact with otherbacteriophage T4 or host proteins. The
column used in the affinity experimentwas Affi-Gel 15, which is an N-
hydroxysuccinimide ester of a derivatizedcrosslinked agarose matrix (Figure
IV-12). Affi-Gel 15 is distinguished fromother affinity supports by containinga
positive charge in its 15-atomspacer arm.
For high coupling efficiency usingAffi-Gel 15 the manufacturerrecommends
that the matrix and protein be incubatedin a buffer that is above the pl ofthe
protein. Under these conditions theprotein of interest carriesa net negative
charge during the coupling reaction andis not repelled from the positivematrix.
A second type ofagarose affinity matrix, Affi-Gel 10, containsa neutral
charged spacer, and is recommendedto be coupled in a buffer ator below the
pl of the protein. For the abovereasons the Affi-Gel 15 is generally used with
acidic proteins while Affi-Gel 10 isused with neutral to basic proteins.
However, when looking at weakprotein-protein interactions themost
important factor in carryingout affinity chromatography isnot the coupling
efficiency of the bound protein, butthe ability of the bound proteinto interact
with and bind soluble proteins ina manner that resembles the interactionfound
in vivo.If the protein-protein interactionsbeing studied are dependenton ionic
interactions it is possible thata majority of the proteins binding to theaffinity
column may carry a net charge thatis opposite to that of the boundprotein, i.e.,
a bound acidic protein will bind mostlybasic proteins, and a basic proteinwill
tend to bind negatively chargedacidic proteins. An affinity columnmatrix that is
opposite in charge to the boundprotein allows efficient couplingbut may
interfere with protein-proteininteractions due to the fact thatthe matrix would
have the same chargeas the soluble protein which have weakaffinities to the
bound protein.CH3 Ck
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Figure IV-12. Structure andCoupling Reaction of Affi-Gel 15.
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For the aforementionedreasons the affinity gel selected to bind RegA,a
positive protein with a pl of 9.8,was Affi-Gel 15, which also carries a positive
charge. To attenuate the charge-chargerepulsion during the coupling reaction
a high ionic strength buffer was used containing 0.3 MNaCI. Under these
conditions the RegA protein was able to becoupled to the positive matrix ata
yield of 66%.
The Affi-gel 15 RegA column retaineda number of T4 and E. coil proteins
that eluted at low NaCI concentrationsas seen in Figure IV-10. The amount of
labeled T4 proteins retainedon the RegA column was significantly higher than
found with the ethanolamine-blockedcolumn matrix or a control BSA Affi-gel
15 column as seen in Figure IV-9.The majority of the proteins retainedon the
RegA column showed weak interactionand were eluted at low NaCI
concentration of 200 mM. Two prominentT4 proteins were found to be eluted
at a NaCI concentration of 600 mM,while 4 E. coil proteinswere found to be
eluted at the higher salt wash of 600mM. However the two prominent T4
proteins that were eluted at 600 mMwere also eluted by the control columns.
A majority of the bacteriophage T4early proteins have been identifiedand their
apparent molecular weight migrationsare known. Table IV-2 represents the
tentative identification of the T4proteins bound to the RegA columnbased
upon their migration values through polyacrylamidegels. Several of the early
T4 proteins that were eluted couldnot be identified because they didnot have
distinctive molecular weights thatallowed unambiguous identification.
The preliminary identificationsof the T4 proteins suggest thatthey are
involved in DNA replication. Whilethe most prominent bandscorresponded to
the migration values of the DNApolymerase accessory proteins onlya weak
band was eluted at 200 1.1M NaCIfor DNA polymerase.111
Table IV-2 Tentative Identification of BacteriophageT4 Early Proteins that
Specifically Associate with an Affi-gel 15 RegA Column
Early T4 Proteins Eluted at 0.2 M NaCI
Mol. Wt. Observed Tentative Identification by apparent MW
58,000 gp39 DNA topoisomerase, subunit large
57,500 gp41 primase subunit,
47,000 gp52 DNA topoisomerase, subunit small
46,500
36,000 gp44, DNA polymerase accessory protein
34,000 gp32, Single stranded DNA-binding protein
33,500
33,000 pse Tor
td, Thymidylate synthase
28,000 gp45, DNA polymerase accessory proteinor
gp42 dCMP hydroxymethylase112
The generation and purificationof anti-RegA rabbit antibodywas successful
but the yield was low. Due to thesmall supply of RegA proteinfurther booster
injections of the rabbitswas not possible. Due to the small yieldof affinity
purified antibody an attemptwas made to generate anti-idiotypicantibodies in
mice. This cross immunizationof rabbit Fabs into micehas been a successful
method to generate anti-idiotypicantibodies in the past andwas a
recommended method ina review for the generation ofanti-idiotypic antibodies
(Catty, D. and Raykundalia,1988).
The injection of the Fab anti-RegAdeveloped a response. However,non-
specific rabbit Fab was alsorecognized, demonstrating thatat least part of the
response was to a structural region of theFab fragment and not theprotein-
protein interaction site.
After the first series of boosterinjections a strongresponse was seen
generated in the mice to boththe anti-RegA Fab fragmentsand to the anti-
RegA IgG. However,no response was seen in the firsttest bleeds to T4-
infected E. col; lysates. Afteradditional boosts immunoprecipitationswere
carried out with themouse serum samples.
As shown in Figure IV-6,the initial immunoprecipitationsusing an anti-
idiotypic serum sample broughtdown a number of T4proteins but no E. col;
proteins. A control usingpre-immune mouseserum did not immunoprecipitate
the T4 proteins. Furtherexperiments showed that theimmunoprecipitation of
T4 proteins was dependenton the type of buffer used duringthe incubations of
sera with the labeled extracts. Asecond finding was that thecontrol mouse
serum which was injected with onlyFreund's complete adjuvantalso brought
down a large number of T4proteins, Figure IV-7.
Specifically, imunoprecipitationsusing NP-40 buffer broughtdown a
number of T4 proteins bothin the serum samplescollected from anti-RegAFab113
injected mice and in the Freund's injectedcontrol mouse. However,
immunoprecipitations carried out in themore stringent RIPA buffer did not bring
down the T4 proteins when usingserum from either anti-RegA injected miceor
the Freund's control, Figure IV-9.
From the following immunoprecipitationsit was concluded that the T4
proteins that were immunoprecipitatedwere due to the repeated injections of
Freund's complete adjuvant and not dueto the generation of anti-idiotypic
antibodies mimicking the RegA bindingdomains.
Freund's complete adjuvant containsa suspension of heat killed
Mycobacterium butricum or Mycobacteriumtuberculosis. The repeated
injections of the denatured bacterialproteins to induce ascites fluidmay be the
cause of the high backgrounds seen in theimmunoprecipitations using NP-40
buffer.
Discussion
The RegA protein is believedto be a global regulator of bacteriophageT4
early genes. The biological significanceof this global regulation is not well
understood. The RegA protein has beencloned and overexpressed but littleis
known about the functional domainsof the protein. Although the RegAprotein
is nonessential during normallaboratory growth, it has been shownto be
highly conserved in most phagesstudied ( Miller and Jozwik, 1990).
The attempt to generate RegAanti-idiotypic antibodieswas not successful
in this study. The attempt togenerate ascites fluid using repeatedinjections of
Freund's complete adjuvant createdextremely high backgrounds inthe
immunoprecipitations that were carriedout under mild conditions. No T4
proteins were immunoprecipitatedwith the supposed anti-idiotypicsera when114
a more stringent buffer, RIPA, was used in theimmunoprecipitations. This
leads me to conclude that eitherno anti-idiotypic antibodies were generated
that recognized other T4 proteins,or that the anti-idiotypic antibodies
associated weakly with the T4 proteins andwere masked by the high
background signals when NP-40 bufferwas used.
In this study we attempted to determinewhether the RegA protein is
associating directly with the deoxyribonucleotidebiosynthesis enzymes. By
the generation of a RegA affinity columnit was determined that certain T4
proteins do appear to interact with theRegA protein. This is the first direct
evidence that the RegA proteinmay also be involved in protein-protein
interaction within the T4-infected E.coll. Most of the associationswere
disrupted at a relatively low saltconcentration of 200 mM NaCI. Two T4
proteins did show higher affinityand were eluted at 600 mM NaCI.
From past work the molecularweight migration on polyacrylamidegels of
most of the early T4 proteins is known.The identification of the elutedproteins
cannot be conclusively made by justthe molecular weight migrationsdue to
many early T4 proteins having equivalentvalues. However, from thetentative
identifications a patternemerges with the eluted proteins likely beingproteins
involved in T4 DNA replication.Enzymes involved in T4deoxyribonucleotide
biosynthesis may also be binding tothe RegA column, but thiscan only be
conclusively demonstrated by additionaltwo-dimensional electrophoresis of
the eluted proteins.
A past proposal for the biologicalrole of the RegA protein suggestedthat it
assisted in the formation of the DNAreplisome (Campbell and Gold,1982).
This initial investigation forprotein-protein interactions involvingthe regA
gene product gives preliminary supportto Campbell and Gold's theorythat the115
RegA protein is a "nonessential"component of the replication complex. Further
study of the protein-protein interactions ofRegA may uncover the significance
that RegA has on the biology of T4. The RegAprotein may still prove to be a
bridge between bacteriophage T4 DNAreplication and dNTP biosynthesis.116
Summary and Future Directions
The research described in thisthesis demonstrates that thegeneration
of anti-idiotypic antibodiescan provide information onenzyme protein-
protein interactions. The identificationof a dCMP hydroxymethylaseanti-
idiotypic antibody that recognizesthe bacteriophage thymidylatesynthase
implicates a direct interaction betweenthe two enzymes. Thedetermination
that the anti-idiotypic antibodyis specific for the phageencoded thymidylate
synthase, strengthens theargument that the antibody isdemonstrating a
direct interaction between thetwo enzymes.
Previous studies using affinitychromatography had identified the T4
thymidylate synthaseas being one of approximatelya dozen proteins that
interacted with the immobilizeddCMP hydroxymethylase.However, the
affinity experiments did notresolve the question of whichproteins were
directly interacting with theimmobilized enzymeor which were binding in a
"piggyback", or indirect, fashion.
What biochemical functionwould be served by havingthe T4
thymidylate synthase and dCMPhydroxymethylase interact? Asmentioned
in the introduction there isprecedent for a thymidylatesynthase active site to
be localized near a secondcatalytic site.In the case of parasiticorganisms
the thymidylate synthasesare known to be bifunctionalenzymes containing
a dihydrofolate reductase activity withinthe same gene. Thecarboxy-
terminal side of the bifunctionalpolypeptide containsa thymidylate synthase
sequence that is very homologousto other thymidylate synthaseswhich do
not show multiple activities.117
The purpose for the bifunctionalnature of the parasitic enzyme has not
been clearly demonstrated. A possibleadvantage for having the
dihydrofolate reductase linked to thethymidylate synthase is the protection
of the labile cofactor.
A possible role for the interaction ofthymidylate synthase and dCMP
hydroxymethylase in bacteriophage T4 wouldnot be the protection of a
substrate but more likely the regulationof the end products, dTTP and hm-
dCMP.
From an organism's point of viewevolution has not selected for the
excellence of a single enzyme but ratherthe controlled output of the entire
pathway which the enzyme is involved(Friedrich, 1984). While the
interaction of the thymidylate synthasewith the dCMP hydroxymethylase
may not improve the ability of the twoenzymes to catalyze their respective
reactions the associationmay allow better coordination of their
deoxypyrimidine products.
My research demonstrates thatthe anti-idiotypic antibodyrecognizes a
unique feature on the T4 thymidylatesynthase which the hostenzyme does
not possess. Mapping the epitopebinding domain of the anti-idiotypic
antibody could in theory identify theprotein-protein binding domainon the
bacteriophage thymidylate synthaseand within the lastyear I have pursued
the mapping of the epitope bindingdomain between the anti-idiotypic
antibody and thymidylate synthase.A variety of techniqueswere attempted
to map the epitope site includinglimited proteolysis of thethymidylate
synthase and generation of C-terminaldeletions of the cloned tdgene.
Both techniques failed tomap the epitope site. A major hurdle inthe
atte:t1pts to map the epitope site isthat the antibody only recognizesthe118
native T4 thymidylate synthase andnot the denatured protein.
Recent efforts to map the epitope site haveinvolved generation of C-
terminally truncated thymidylate synthasesusing an in vitro transcription-
translation system. With this technique Ihave determined thateven a small
deletion into the C-terminal regionprevents recognition of thymidylate
synthase by the anti-idiotypic antibody.This result implies that either the
thymidylate synthase C-terminal regioncontains the epitope siteor that the
C-terminal region is needed for the overallcorrect conformation of the
enzyme. It may prove that the intact dimer of T4thymidylate synthase is
required for the presence of thedCMP hydroxymethylase bindingdomain.
Therefore, mapping of the epitopeby cleavage of the thymidylatesynthase
protein or by deletion ofsequence within the open reading frame willbe
ineffective.
Characterizing the interaction of thethymidylate synthase with dCMP
hydroxymethylase through in vitroreconstitution of the twoenzymes should
be carried out.I have carried out purificationsto homogeneity of both the
thymidylate synthase and the dCMPhydroxymethylase for future studies.An
interesting and worthwhile futurestudy would be the determinationof the
effect upon the interaction of thetwo enzymes in the presence ofsubstrates,
deoxyribonucleoside monophosphatesor methylene tetrahydrofolate.
A currently unexplained observationis the apparent high affinitythat the
dCMP hydroxymethylase anti-idiotypicantibody has for T4 thymidylate
synthase while the initial studiesusing the two enzymessuggest a weak
protein-protein interaction. This paradoxsuggests that the anti-idiotypic
antibodies' binding domain doesnot truly mimic the dCMP
hydroxymethylase surface and is insteadan analog surface which has119
higher affinity than the original bindingdomain.
The generation of the polyclonal anti-idiotypicserum probably contained
a number of different anti-idiotypic antibodies whichhad a wide spectrum of
affinities that were analogous to the dCMPhydroxymethylase protein-protein
binding domain. The anti-idiotypicantibodies with high affinities for
thymidylate synthase were able to maintaintheir interaction during the
immunoprecipitations while weaker affinityanalogs failed to
immunoprecipitate labeled proteins.If this proposal is correct it pointsto a
possible problem with theuse of anti-idiotypic antibodies, the anti-idiotypic
antibodies may have affinities that donot reflect the true strength of the
actual interaction between thetwo macromolecules.
Examination for protein-protein interactionsinvolving the transcriptional
regulator, RegA, demonstrated thatthe immobilized translationalrepressor
had specific affinities for E. coli andother T4 proteins. An attemptwas
made to identify the T4 proteinsthat were retained on the affinitycolumn.
The migration valueson polyacrylamide gels of known T4 proteinswere
used in an attempt to identify theinteracting proteins. However, thisinitial
identification was not conclusive andleaves in doubt the identificationof a
majority of the proteins.
Future research involving theuse of 2D electrophoresis of the eluted T4
extracts would validate the initial conclusionthat RegA is associating with
replication proteins at low tomoderate ionic strengths.In addition, the
identification of the E. coil proteinsthat were retained on the affinitycolumn
would also be useful in understandingthe role that RegA has withinthe T4
infected E. coli.Finally a comparison of the elutionpatterns attained with
RegA bound to both a positiveagarose matrix and a neutral affinity column
would be an appropriate futurecontrol to confirm specific interactionsof the120
RegA protein.
The attempt to generate anti-idiotypicantibodies to RegA by the injection
of rabbit Fab fragments into mice provedproblematic. While unsuccessful, it
did demonstrate the limits andpossible pitfalls with generatinganti-idiotypic
antibodies. The repeated use of Freund'scomplete adjuvant created high
non-specific backgrounds in theimmunoprecipitations using our standard
incubation buffer.121
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APPENDIX A.
Association of the Large Subunit of Ribonucleotide Reductase with He La Cell
Mitochondria
Another project on which I have also spenta considerable amount of time,
examined the association of ribonucleotide reductase withHe La mitochondria.
This project is a continuation of the work initiated by Janet Leeds.I have
concentrated my efforts on attempting to determine if the low levelof
ribonucleotide reductase activity associated with mitochondria isbiologically
significant or if it is due to contamination from the cytoplasm.
Introduction
Past work by Janet Leeds involved the isolation of intactmitochondria and
assaying the extracts for deoxynucleotide metabolizingenzymes.
Ribonucleotide reductase assays whichwere carried out by Dr. Mary Slabaugh
demonstrated that 3% of the whole-cell activitywas associated with the
mitochondria (Leeds, 1987). More interestingwas the observation that 1.0 mM
dATP, while inhibiting 96% of the whole-cell activity,stimulated the
mitochondria! associated activity two-fold.I initiated a project to determine if the
observed differences in the regulation of activitywere due to a unique form of
ribonucleotide reductase being present in the mitochondria.
The initial experiment involved isolating mitochondriafrom rapidly dividing
He La cells and carrying out immunoblotson cytoplasmic and mitochondrial
fractions. The antibody selected to probe theimmunoblots was a monoclonal
antibody, AD203, which is specific for the mammalianlarge subunit (Engstr6m,
1982). The large subunit, R1, contains nucleotide-bindingsites that regulate133
enzyme activity. The AD203 monoclonal antibodywas selected because it had
very low cross-reactivity with other proteins.It was expected that a unique
mitochondrial large subunit would either benon-cross reactive with the
antibody or would be shown to havea molecular weight that was different from
the cytoplasmic form.
Material:
The AD203 monoclonal antibodywas purchased from InRo Biomedtek. The
glyceraldehyde-3-phosphate dehydrogenase polyclonalantibody was a gift
from Dr. Ann Brodie. Nitro Screen West immunoblotmembrane was purchased
from NEN Research, Dupont. Trypsin-EDTA,0.05% trypsin, 0.53 mM EDTA,
was purchased from Gibco.
Mitochondrial Isolation Procedure:
He La cells were removed from the cellculture plates by either trypsin
digestion or by scrapping witha rubber policeman. The mitochondriawere
isolated using the protocol described in appendixB. For the comparison of
trypsin sensitivity a He La 1 ml cell homogenatewas incubated at 37°C in the
presence of 100 gl trypsin-EDTA, 0.05% trypsin, 0.53 mMEDTA, for 15 minutes.
The proteolysis was stopped with the 1:50addition of 20 mg/ml PMSF. The
mitochondria were then purifiedas described in appendix B. Additional
purification of the mitochondrial extractswere carried out by sucrose gradients
as described in appendix C. The He La fractionswere also fixed and examined
under a transmission electron microscopeto determine purity.
A polyclonal antibody to glyceraldehyde-3-phosphatedehydrogenase was
used as an example of non-specific associationof an enzyme with membranes.
The mammalian glyceraldehyde-3-phosphatedehydrogenase is a known134
cytoplasmic enzyme which has been foundto adhere non-specifically to plasma
membrane and organelles (Ryzlak and Pietruszko,1988). The purpose of this
control was to determine if the large subunithad a similar associationas the
non-specific glyceraldehyde-3-phosphatedehydrogenase.
Results
Initial immunoblots using the anti-R1antibody clearly demonstrateda
difference in the molecular weights of thecytoplasmic and mitochondrial R1
protein, see lanes 1 and 4, Figure 1. However,additional work determined that
the difference in the molecular weightpattern was not due to a distinct
mitochondrial form of ribonucleotidereductase large subunit. Instead the
difference was determined to bean artifact from the trypsin isolation procedure
used to detach the He La cell monolayerfrom the cell culture plates.
When He La cells were isolated bymechanical scraping the R1 immunoblots
were identical in molecular weight, see lanes 3and 4, Figure 1. The trypsin
sensitivity of R1 proved fortuitous in thatit demonstrated a distinct difference
between the R1 subunit found in thecytoplasm and that whichwas present in
the crude mitochondrial fraction.
The trypsin treatment ofa homogenized cell extract confirmed that the
mitochondrial R1 was sequesteredaway from the protease, see lanes 2 and 5,
Figure 1.Finally by probing with the polyclonalantibody to glyceraldehyde-3-
phosphate dehydrogenase itwas determined that both the cytoplasmicand
crude mitochondrial fractions containedglyceraldehyde-3-phosphate
dehydrogenase enzyme.
To compare the localization ofthe R1 subunit and the non-specificbinding of
glyceraldehyde-3-phosphate dehydrogenasean additional sucrose gradient
purification step was carried outon a mitochondrial fraction. Asseen in Figure
2, the R1 subunit co-migrated withthe intact mitochondria, whilethe135
glyceraldehyde-3-phosphate dehydrogenaseenzyme was distributed
throughout the gradient.
From repeated mitochondrial purifications andimmunoblots it was
determined that a mitochondria' proteinextract contains approximately as much
R1 subunit as does an equal fraction ofcytoplasmic extract. In other words, the
R1 immunoblot for the cytoplasmic andmitochondrial fractions are of roughly
equal intensity when an equivalentamount of total protein is loaded onto each
lane of the gel. However, the total amount ofpurified mitochondrial protein is
much lower than the amount of total proteinfound in the whole cytoplasmic
fraction, roughly 5%. Also the amount oftotal mitochondria' protein present
after purification varies greatly with each HeLa cell homogenization.
Examination of the mitochondria' fractions witha transmission electron
microscope, TEM, showed that the mitochondrialextract appeared to be fairly
pure and fragments of cell membrane, nuclear membraneor other organelles
were not in abundance. The use of TEM showed thatthe mitochondria were
swollen and many appeared to have losttheir outer membranes. Inspection of
the homogenized He La cell pellet showeda large proportion of organelles
entangled within the lysed cell bycytoskeletal material and thereby preventing
the release of many of the mitochondria.This observation may explain the low
yield of mitochondria obtained from theHe La cells.
Discussion
The occurrence of enzymes in multiplemolecular forms, isozymes, isa
common motif found within in cells of higher organisms.It has recently been
demonstrated that Saccharomyces cervisiaeencodes two alternate large
subunits of ribonucleotide reductase, RNR1and RNR3. Under normal growth
conditions the gene product of RNR1 isused to form the nativeenzyme with136
the small subunit. However, after theoccurence of DNA damage the RNR3 is
expressed (Yagle and McEntee, 1990).It would seem likely that other
eukaryotic cells could contain multiple molecularforms of the ribonucleotide
reductase enzymes.
Past work had identified low level ribonucleotidereductase activity localized
with He La mitochondria. The use of immunoblotsdemonstrated that the
mitochondrial extract contained a ribonucleotidereductase large subunit that
migrated at the same molecular weightas found in the cytoplasm, indicating
that the mitochondrial R1 is nota unique form. However, the protection of the
mitochondrial R1 from proteolysismay indicate internalization of the enzyme
within the mitochondria.97 k
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Figure A-1. Immunoblot Analysis of TrypsinTreated He La Fractions. Lanes 1
and 4 correspond to fractionations of He La cellswhich were isolated by trypsin
treatment of the cell plates. Lanes 2,3,5, and6 represent fractionations of cells
that were collected by mechanical scrapingof the plates. After homogenization,
a cell lysate was incubated with trypsin for 15 minutesat 37°C and the
proteolysis stopped with protease inhibitor,PMSF. The mitochondriawere then
purified from the treated homogenate. Lanes2 and 5 represent the trypsin
treated fractions. Lanes 5 and 6are untreated control fractionations. The
immunoblot was also probed witha glyceraldehyde-3-phosphate
dehydrogenase antibody asa control.R1
GDH
Bottom
intact
mitochondria Top
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Figure A-2. Immunoblot Analysis of Sucrose Gradient Purification of He La
Mitochondrial Extracts. A sucrose gradient purification of crude He La
mitochondria was carried out as described in appendix C. The density of the
fractions was determined by the use of a refractometer. The position of intact
mitochondria was also confirmed by measuring the collected fractions for citrate
synthase activity. The top western represents the anti-R1 immunoblot of the
sucrose fractions, while the bottom immunoblot was probed with anti-
glyceraldehyde-3-phosphate dehydrogenase. The large subunit of the
ribonucleotide reductase was found to be located at the top of the gradient and
also present with the intact mitochondria. The anti-GDH was distributed
throughout the gradient and not localized with the mitochondria.139
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APPENDIX B.
Purification of Mitochondria From Cell Culture.
1. He La cells are typically grown in MEM mediasupplemented with
glutamine, penicillin/streptomycin, and 5% bovine calfserum.
2. Grow He La cells to 75% confluency, trypsinize cellsoff the cell culture
plates and plate out in fresh media at 60% confluency.The 24 hour pre-
trypsination helps weaken the cell membrane for latercell rupture.
3. Aspirate off the medium and and wash plateswith Ca2+ Mg2+ free PBS.
Scrape cells off the plates with a sterilized rubberpoliceman. To prevent the
cells from drying out have approximately 2 ml of PBSon each plate when
scrapping the cells.
4. Rinse cells off the plates with PBS andplace solution in 30 ml corex
tubes.
5. Perform all further manipulationson ice at 4°C; use MilliQue water for all
solutions.
6. Spin cells down in Sorvall SS34 rotor, 2500rpm, 3 minutes. Resuspend
with three pellet volumes of Ca2+ Mg2+-freePBS. Freeze He La cells in-
70 °C freezer overnight or longer. An alternativemethod is to freeze the cells
in liquid nitrogen and precede directlyto the next step.
7. Allow the cell suspension to melt andagain spin cells down in Sorvall
SS34 rotor, 2500 rpm, 3 minutes. Removethe cloudy supernatant and
resuspend the cell pellet in 1 cell volume of,0.25 M sucrose, 1mM EGTA,
0.5% BSA, 10 mM Hepes -NaOH, pH 7.4.
8. Place the cell suspension ina glass/teflon homogenizer and disrupt the141
cell membrane with 8 strokes of the piston. Confirm celldisruption by
examining a 1/50 dilution of the extract ina cytotometer. Compare the
difference between an untreated fractionversus the homogenized extract.
9. Spin the homogenized extract in 1.5 ml microfugetubes at 500 g to pellet
the cell membrane. Place the supernatant in 1.5-m1 microfugetubes and
spin the crude mitochondria a second time at 500g.
10. Pellet the mitochondria by spinning at 16,000g, save the supernatant as
cytoplasmic fraction.142
APPENDIX C.
Sucrose Gradient Purification of Mitochondria
1. Prepare the sucrose gradients the night before theactual run. Stack 2.0,
1.6, 1.3, 1.0 M sucrose,1mM EDTA, 0.1% BSA, 10 mM Hepes -NaOH,on
top of each other in SW41 tubes. After pipettinga fraction into a tube, freeze
with liquid nitrogen and then apply the next lowersucrose solution. Allow
the tubes to liquify at 4°C overnight. A continual gradientwill be formed after
12 hours.
2. Place the crude mitochondria on the gradientsand run in an
ultracentrifuge SW 41 rotor at 80,000g for 2 hrs at 5°C.
3. Collect 500111fractions into 1.5 ml microfugetubes, by punching a hole in
the bottom of the centrifuge tubesor by pippeting off the top.
4. Measure the density of the fractions usinga refractometer. Intact
mitochondria should sediment at 1.19 g/ml.
5. Dilute the samples with 2 volumes of 1 mMEDTA, 10 mM Hepes, pH 7.4.
Centrifuge at 16,000 g, 20 minutes. Resuspendpellets and repeat
centrifugation to remove BSA containing gradientsolution.
6. Assay fractions for mitochondrial activity,such as citrate synthase. Store
samples at -20°C.APPENDIX D.
RbCl2 Method for Competent Cell Making
RbCl2 Buffer
Millique water
pH to 5.7 with 1N HCI
Filter sterilize
100 mM RbCl2
45 mM MnCl2
10 mM CaCl2
35 mM CH2COOK
15% (WN) Sucrose
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SOB & SOC Media:
To 950 ml of Millique water, 20g bacto-tryptone, 5 g bacto-yeast extract, 0.5g
NaCI, 0.18 g KCI, 1 ml 1 N NaOH. Autoclave20 min. Just before use add 10 ml
1 M MgCl2 and 20 ml 1 M MgSO4. For SOCmedia same as SOB medium
except add 20 ml 1 M glucose per liter, 20 mM finalconc.
All glassware, SOB & SOC media flasks, incubatortest tube, incubator flask,
corex tubes, should be washed 3x with millique water andautoclaved
containing millique water.
1. Start cells from -80° C stock. Very importantto streak out on a plate the night
before.
2. Place 4-5 regular shaped colonies into2 ml SOB media, vortex. Shake at
300 rpm 37°C until A600approx. 0.8. Dilute the culture into a second flaskso
that the A600 does not exceed 0.06. Youwill want 5 ml for every
transformation.
3. Measure A600 every 20 minutes.If the A600 is not doublingevery 20
minutes your transformation efficiency willbe lower than optimum.
4. Grow cells in SOB media to A600 of0.3, - 5x107 cells /mi. Place in clean
corex tubes on ice 5 minutes.
5. Spin cells down 3,000rpm SS34 for 3 minutes. Pour off media and aspirate
off as much media as possible.
6. For each 5 ml of cells gently resuspendwith 1 ml ice cold RbCl2 buffer in the
corex tubes.
7. Spin cells down 3,000rpm SS34 for 3 minutes. Pour off buffer, add200 gl of
ice cold RbCl2 buffer per transformation,resuspend gently.
8. Place 200 gl of bacteria in eachpolyprop. tube. Add DNA to tubesand as a144
control add 1 ng of supercoiled plasmid DNA toone tube. Gen* rock tubes on
ice for 1 hr.
9. Heat shock for 90 seconds at 42°C, do not shake, coolon ice 2 min.
10. Add 1 ml SOC media, no antibiotic, 37°C for 45minutes. Slow speed on
shaker, 225 rpm. The polyprop. tubes should be standingvertically.
11.Spread out on plates, 100 gl, 50 gl, 1 gl for each.For 1 gl dilute with 100 RI
media before spreading.145
APPENDIX E
Mini-Prep Method
1. Grow a 3 ml bacterial culture to an A600 of 0.8 and add chloroamphenicolto
a final concentration of 170 14/ml, stock solution is in ETOH 34 mg/ml. Grow for
12 more hours
2. Transfer 1.5 ml of the bacterial culture into 1.5 ml eppendorftubes
3. Centrifuge for 1 minute and aspirate off the mediasupernatant.If your
plasmid is expressed at a low copy number add the remaining1.5 ml to the
eppendorf tubes and repeat steps 2 and 3.
4. Add 300 ul STET to each tube. Make the STET bufferup fresh
STET 100 ml
Sucrose 8% 8 g
Triton X 0.5% 0.5 ml
EDTA pH 8.0 50 mM 10 ml of 0.5 M EDTA
Tris pH 8.0 10 mM 1 ml of 1 M Tris
5. Prepare lysozyme cocktail: (Recipe shown is for 24samples) 10 mg
lysozyme.1 ml TE (Mix by vortexing)
6. Add 25 ul lysozyme cocktail to each eppendorf tube.
7. Resuspend pellets by repeated pipettingor vortexing.
8. Place samples in a rapidly boiling water bath for40 seconds
9. Centrifuge for 2 minutes. Pull the white gel like"goober' pellet out with a
toothpick. For a successful miniprep the pellet shouldbe approximately 20-
50% of the liquid volume. A very small chalk like pelletthat does not stick to the
toothpick is a bad omen. Also a pellet that is larger thanthe supernatant is also
a bad sign.
10. Add 300 gl isopropanol to each tube andvortex.
11. Centrifuge for 10 minutespour off the supernatant and spin the tubes an
additional 5 minutes. The second spin without thesupernatant brings the DNA
to the bottom of the tube and off the sides of the eppendorftubes.146
12. Carefully aspirate off the rest of the liquid andadd 166 pl TE buffer or water
to each tube. Resuspension is much easier if allowedto soak a half an hour to
an hour. This is a good place to stop by storing the tubesat 4° C or -20° C.If
the plasmid DNA is to be used for sequencing, itshould be stored at 4° C only,
and used within a week. When using highcopy number plasmids, the
minipreps may be used at this point, to further cleanup do the following ETOH
precipitation.
13. Resuspend pellet with a yellow pipet tipor by vortexing.
14. Add 83 p1 7.5 M ammonium acetate and(An optional step to help cleanup
minipreps is to centrifuge for 2 minutes andplace the supernatants intonew
eppendorfs).
15. Add 500 41100% ETOH. Place inthe -80°0 for 15 minutesor longer.
16. Centrifuge for 10 minutespour off supernatant and spin an additional 5
minutes.
17. Aspirate off any additionalsupernatant and pipet 1 ml 70% ETOH fromthe
20° C freezer into each sample beingcareful to not disturb the DNA pellet.
18. Aspirate off ETOH, centrifugefor 30 seconds and remove final ETOH.Allow
to air dry, approx 10 minutes.
19 Bring pellets up in TE bufferor in water, 20 -100 pi dependingon DNA pellet
size.
20. (optional) Determine DNAversus protein concentration using Warburg
spectrophotometric program. 1µg/u1 isa common and successful result.